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ABSTRACT 
In order to form tissues and to move, cells need to attach to the surrounding 
environment. Integrins are the major cell adhesion receptors that cells use to attach 
to the extracellular matrix on the outside of the cell, and to recruit a large adhesion 
complex on the intracellular side. As transmembrane proteins, integrins have an 
important role in mediating bidirectional signalling across the plasma membrane. 
Moreover, the integrin-based adhesions are linked to the actin cytoskeleton and 
thereby act as a link between the extracellular matrix and the actin cytoskeleton. The 
actin cytoskeleton is responsible for the cellular force generation, and integrin-based 
adhesions and the actin cytoskeleton create thereby a machinery, that cells can use 
for example to move. Moreover, integrins and the actin cytoskeleton can mediate 
reactions to extracellular cues and even alter gene expression. Both integrin activity 
and the actin cytoskeleton are carefully regulated, and mutations in genes encoding 
for integrin and actin regulators associate with plethora of diseases. However, less is 
known if integrin-based adhesions and the actin cytoskeleton are regulated by the 
same factors. 
In this thesis, I have investigated the role of two known integrin inhibitors, 
SHANK3 and SHARPIN, in regulation of the actin cytoskeleton, and whether this 
occurs synergistically with regulation of integrins and cell adhesion. I have 
characterised novel interaction partners for both SHANK3 and SHARPIN, and 
defined their functions in regulating the cellular actin cytoskeleton, cell adhesion and 
cell migration. Furthermore, I have investigated how SHARPIN regulates integrin 
activity at tissue level and find that integrin inhibition can ameliorate the effects of 
SHARPIN loss in vivo. Importantly, the findings presented in my thesis provide 
novel insights that can be used to understand pathogenesis of cancer, 
neuropsychiathric disorders and psoriasis-like dermatitis. 
KEYWORDS: actin, cancer, cell adhesion, cell migration, cytoskeleton, dermatitis, 
integrins, SHANK, SHARPIN 
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TIIVISTELMÄ 
Solut kiinnittyvät ympäristöönsä muodostaakseen kudoksia ja liikkuakseen. 
Integriinit ovat keskeisessä asemassa olevia solun tarttumisreseptoreja, joita solu 
käyttää kiinnityäkseen solun ulkopuolella soluväliaineeseen ja sisäpuolella muiden 
proteiinien sitomiseen ja siten monia proteiineja käsittävän adheesiokompleksin 
muodostamiseen. Integriinit läpäisevät solukalvon ja kykenevät siten välittämään 
signaaleja solun ulkopuolelta solun sisälle, ja solun sisäpuolelta ulkopuolelle. 
Lisäksi integriinit sitoutuvat välillisesti solun aktiinitukirankaan muodostaen siten 
yhteyden soluja ympäröivän soluväliaineen ja aktiinitukirangan välille. Solun 
aktiinitukiranka on vastuussa mekaanisten voimien tuottamisesta solussa, ja yhdessä 
integriinit ja aktiinitukiranka muodostavat koneiston, jonka avulla solu pystyy 
liikkumaan. Ne voivat myös yhdessä lukea solun ympäristön ominaisuuksia ja 
välittää siten säätelyä, jolla solu sopeutuu ympäristöönsä ja sen muutoksiin. Sekä 
integriinit että aktiinitukiranka vaativat tarkkaa säätelyä, ja mutaatiot niitä 
säätelevien proteiinien geeneissä ovat yhteydessä moniin erilaisiin sairauksiin.  
Tutkin tässä väitöskirjassa miten kaksi integriinien säätelijöiksi tunnistettua 
proteiinia, SHANK3 ja sharpiini, vaikuttavat myös aktiinitukirankaan ja tapahtuuko 
tämä säätely yhdessä vai erikseen integriinien säätelyn kanssa. Kuvaan uusia, suoria 
vuorovaikutuksia sekä SHANK3:n että sharpiinin ja muiden solun proteiinien 
välillä. Lisäksi tutkin miten SHANK3 ja sharpiini vaikuttavat näiden uusien 
toimintojensa kautta solun aktiinitukirangan säätelyyn, solujen kiinnittymiseen 
ympäristöönsä ja solujen liikkumiseen. Lisäksi kartoitin miten sharpiini säätelee 
integriinien aktiivisuutta kudostasolla ja osoitin kuinka integriinien toiminnan 
estäminen voi lieventää sharpiinin geneettisen puutteen aiheuttaman tulehdusta. 
Väitöskirjani löydökset tarjoavat uutta tietoa, joka voi auttaa ymmärtämään syövän, 
neuropsykiatristen sairauksien ja psoriasikseksen tautimekanismeja paremmin. 
AVAINSANAT: aktiini, integriinit, SHANK, sharpiini, solujen liikkuminen, solun 
tukiranka, syöpä, tarttumisreseptorit 
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Arp2/3 actin-related protein 2/3 
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ADP adenosine diphosphate 
ARR ankyrin repeat region 
ASD autism spectrum disorders 
ATP adenosine triphosphate 
BSA bovine serum albumin 
CNS central nervous system 
cpdm chronic hyperproliferative dermatitis 
DMEM Dulbecco’s Modified Eagle’s Medium 
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ERM ezrin-radixin-moesin 
FACS fluorescence-activated cell sorting, flow cytometry 
F-actin filamentous actin 
FAK focal adhesion kinase 
FBS fetal bovine serum  
FL full-length 
FRAP fluorescence recovery after photobleaching 
G-actin globular actin 
GAP GTPase activating protein 
GEF guanine nucleotide exchange factor 
GDP guanosine diphosphate 
GFP green fluorescent protein 
GST glutathione S-transferase 
GTP guanosine triphosphate 
HBSS Hank’s Balanced Salt Solution  
HOIL-1 heme-oxidized IRP2 ubiquitin ligase 1 
HOIP HOIL-1 interacting protein 
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INF2 inverted formin 2 
IRSp53 insulin receptor substrate of 53 kDa 
kDa kilodalton 
KO knockout 
kPa kilopascal 
LUBAC linear ubiquitin chain assembly complex 
MEF mouse embryonic fibroblast 
MMP matrix metalloproteinase 
Myo10 Myosin-10 
NF-κB nuclear factor-κB 
NPF nucleation promoting factor 
NZF Npl4 zinc finger 
PBS phosphate buffered saline 
PDZ PSD-95/Discs large/ZO-1 
PFA paraformaldehyde 
PH pleckstrin homology 
PLA proximity ligation assay 
pMLC phospho myosin light chain 
PP polyproline 
PSD postsynaptic density 
PTEN phosphatase and tensin homolog 
RFP red fluorescent protein 
RIAM Rap1-GTP-interacting adaptor molecule 
ROCK Rho-associated protein kinase 
SAM  sterile alpha motif 
SCAR suppressor of cAR 
SH3 Src homology 3 
SHANK SH3 and multiple ankyrin repeat domains proteins 
SHARPIN SHANK Associated RH Domain Interactor 
SPN SHANK/ProSAP N-terminal 
TCR T-cell receptor 
TIRF total internal reflection fluorescence microscopy 
TNFα tumour necrosis factor α 
TNFR tumour necrosis factor receptor 
UBL ubiquitin-like 
VASP vasodilator-stimulated phosphoprotein 
VCA verprolin homology, central acidic 
WASP Wiscott-Aldrich syndrome protein 
WAVE WASP-family verprolin-homologous protein 
WT wild type 
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1 Introduction 
Cells are the building blocks of tissues, such as muscle, liver or brain tissue. In 
addition to cells, tissues consist of extracellular matrix (ECM), also known as 
connective tissue, which provides a framework for the tissue. The ECM is secreted 
by the cells themselves, and it consists mainly of different proteins and 
proteoglycans. In addition to working as a scaffold, the ECM has an important role 
in regulating cell signalling through engaging specific receptors or binding secreted 
soluble signalling mediators such as growth factors. The ECM composition also 
defines the physical parameters of the tissue cells and cells can exert mechanical 
forces to remodel the ECM. Importantly, the ECM acts as a template to which cells 
can adhere to and in which cells can migrate in (Hynes and Naba, 2012; Frantz et al., 
2010). 
Integrin adhesion receptors are transmembrane heterodimers that bind the ECM 
with their large extracellular domains, and recruit other proteins to their intracellular 
tails, which serve as binding platforms for integrin regulatory proteins and adhesion 
components. Importantly, integrin activation triggers formation of cell adhesions, 
which are large protein complexes that participate in force generation and signalling. 
As transmembrane proteins, integrins have a pivotal role in mediating signalling 
bidirectionally across the plasma membrane. Therefore, integrins participate in 
plethora of cellular signalling cascades (Michael and Parsons, 2020; Bouvard et al., 
2013; Hynes, 2002). In this thesis, the focus will be on the role of integrin-based 
adhesions as interfaces between the ECM and the actin cytoskeleton, and how 
integrin activity is regulated at the tissue level. 
Integrin-based adhesions consist of tens to hundreds of different proteins (Horton 
et al., 2015). Importantly, these adhesion-associated proteins connect integrins to the 
actin cytoskeleton. While the integrins make the initial contact with the environment, 
the actin cytoskeleton provides the cells a backbone and muscles. Importantly, 
adhesion-linked actin stress fibers can contract and mediate tension. Therefore, the 
actin cytoskeleton has a pivotal role in maintaining cell shape and mediating cell 
movement (Burridge and Wittchen, 2013; Livne and Geiger, 2016). Together, 
integrin-based adhesions and the connected actin cytoskeleton can read and react to 
the environmental cues, such as rigidity of the ECM, its protein composition and 
Siiri Salomaa 
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topography, but also exert mechanical forces back to the environment (Geiger et al., 
2001; Katz et al., 2000; Elosegui-Artola et al., 2016; Doyle et al., 2012).  
Integrins can be both activated and inhibited by proteins that bind to their 
intracellular tails, and several proteins have been identified to either promote or 
suppress activity of integrins (Askari et al., 2009; Shattil et al., 2010). Function of 
these regulators is crucial, as dysregulated integrin activity associates with multiple 
diseases ranging from inflammatory diseases to bleeding disorders and cancer 
(Bouvard et al., 2013; Hynes, 2002). In addition, the actin cytoskeleton is regulated 
by multiple actin-binding proteins that organize cytoskeletal structures, crosslink 
actin filaments, regulate actin assembly and disassembly and contractility of the actin 
cytoskeleton. Consistently, dysregulated actin cytoskeleton associates with multiple 
diseases, including immune deficiencies and neuropsychiatric disorders (Joensuu et 
al., 2018; Yamaguchi and Condeelis, 2007; Machesky and Insall, 1998). 
Importantly, the diseases associated with dysregulated integrin activity, cell 
adhesion and/or actin cytoskeleton, are often caused by mutations in proteins 
regulating them. This highlights the importance of understanding the roles of 
integrin, adhesion and actin regulators. 
Integrin-mediated cell adhesion and the actin cytoskeleton have been studied 
extensively, but there are still many unanswered questions. Especially crosstalk 
between integrin activity regulation and the actin cytoskeleton awaits further studies. 
In this thesis, I have investigated the role of two known integrin inhibitors, SHANK3 
and SHARPIN, in regulation of the actin cytoskeleton. Furthermore, I have studied 
how SHARPIN-mediated integrin inhibition contributes to the chronic proliferative 
dermatitis phenotype that Sharpin null mice exhibit at the tissue level. The 
observations presented in this thesis will expand our knowledge on how distinct 
proteins can regulate both cell adhesion and the actin cytoskeleton. These findings 
will advance our current knowledge of regulation of integrins, cell adhesion and the 
actin cytoskeleton. Furthermore, they may provide novel information that can be 
used to develop new therapeutic targets in autism-spectrum disorders, cancer and 
psoriasis-like conditions. 
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2 Review of the Literature 
2.1 Cell adhesion and the extracellular matrix 
The tissue consists of cells and the extracellular matrix (ECM). The ECM is a non-
cellular meshwork of fibrous proteins, such as fibronectin and collagen, and 
proteoglycans that surrounds the cells. It provides a physical scaffold for the tissues 
and it is the microenvironment of cells. Furthermore, cells themselves have an 
important role in formation and remodelling of the ECM, as they secrete proteins 
and other factors, such as ECM-modifying enzymes and growth factors, to the ECM 
(Frantz et al., 2010; Hynes and Naba, 2012). The ECM provides structure and form 
to a tissue, and its composition and stiffness varies greatly between different tissues 
(Frantz et al., 2010; Handorf et al., 2015). For example, while the brain tissue has an 
averege stiffness of 1-4 kilopascal (kPa), for the bone this is 15000-20000 kPa 
(Handorf et al., 2015). 
Interactions between cells and the ECM have many distinct purposes. Cells 
adhere to the ECM to anchor themselves, but also to create movement and tensile 
forces. Furthermore, cell-matrix attachment has an important role in cell 
differentiation and mediating signalling to regulate the cytoskeleton and to trigger 
survival signalling for example in synergy with growth factor-dependent pathways. 
Both ECM composition and stiffness are known to regulate organization of the actin 
cytoskeleton and its contractility, cell cycle progression, differentiation of stem cells 
into specific cell types and tissue homeostasis (Frantz et al., 2010; Handorf et al., 
2015).  
2.1.1 Integrins are cell surface receptors that mediate 
bidirectional signalling across the plasma membrane 
Integrins are major cell adhesion receptors, which have a pivotal role in how cells 
interact with their environment and surrounding cells. Importantly, cells use 
integrins to bind and make contacts to the surrounding ECM. Integrins form and 
function as heterodimers of an α and a β subunit, and the known 24 distinct 
heterodimers are combined from altogether 18 α and 8 β subunits. The different 
integrin heterodimers are further classified into RGD-, collagen-, laminin- and 
Siiri Salomaa 
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leukocyte-specific receptors based on their binding substrates (Humphries et al., 
2006; Hynes, 2002).  
Regulation of integrin activity has a central role in how cells interact with the 
ECM, and dysregulated balance in integrin activity associates with various 
pathological conditions, including cancer, bleeding disorders and immunological 
diseases (Bouvard et al., 2013; Hynes, 2002). Importantly, integrins are 
transmembrane proteins, they mediate signalling bidirectionally, and activity of 
integrins can be regulated both from inside-out and outside-in (Hynes, 2002). 
Moreover, integrins can be both activated and inactivated through interactions with 
cytoplasmic integrin regulatory proteins (Bouvard et al., 2013; Calderwood, 2004; 
Gao et al., 2019; Pouwels et al., 2012; Shattil et al., 2010).  
Integrins undergo conformational changes that regulate their affinity towards 
their ligands. Three major conformational stages have been well-characterised: a 
bent, inactive conformation, a primed, extended conformation and an open, fully 
activated conformation (Figure 1.) (Askari et al., 2009; Luo et al., 2007). Bent, 
inactive integrins are held in an inactive conformation through a salt bridge 
interaction between the cytoplasmic α- and β-tails (Campbell and Humphries, 2011). 
They can be switched into an extended primed-active conformation following 
binding of integrin activators to the cytoplasmic β-tail and separating the integrin 
cytoplasmic tails (Campbell and Humphries, 2011; Shattil et al., 2010). This is called 
inside-out activation, whereas outside-in activation is a process where primed, 
unoccupied integrin binds ECM ligand to become fully activated and ligand 
occupied (Askari et al., 2009; Luo et al., 2007; Shattil et al., 2010). Integrins can be 
inactivated and held in an inactivated conformation by recruitment of integrin 
inactivating proteins to the cytoplasmic α- and β-tails (Figure 1.) (Bouvard et al., 
2013; Pouwels et al., 2012).  
Talins are the most well-established integrin activators that bind to the integrin 
β-tail and promote recruitment of other adhesion-associated proteins to the site. For 
example, talins promote recruitment of kindlins to the integrin β-tail, and they co-
operatively regulate integrin affinity (Moser et al., 2009; Sun et al., 2019). 
Furthermore, talin also recruits focal adhesion protein vinculin, and connects 
integrins to the actin cytoskeleton both through vinculin and by directly binding actin 
(Humphries et al., 2007; Sun et al., 2019). Importantly, talin acts as a 
mechanosensitive nexus in adhesion signalling (Goult et al., 2018). Small GTPase 
Rap1 and Rap1-GTP-interacting adaptor molecule (RIAM) recruit talin to the 
plasma membrane and relieve talin autoinhibition promoting thereby integrin and 
actin binding (Goult et al., 2018). The linkage between talin and contractile actin 
structures increases to stretching of talin promoting vinculin recruitment and 
increasing therefore force transmission between integrins and actomyosin structures 
(Yao et al., 2014). This force-induced unfolding of talin also induces RIAM 
Review of the Literature 
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replacement with vinculin, and while integrin-talin-RIAM complex associates 
typically with initial cell protrusion tips, more mature adhesions that have vinculin 
are devoid of RIAM (Lagarrigue et al., 2015; Goult et al., 2018). In addition, the 
linkage between talin and the actin cytoskeleton also further increases integrin 
affinity in a mechanosensitive manner highlighting the importance of mechanical 
signalling in integrin activation (Sun et al., 2019). 
 
Figure 1.  Integrins change conformation gradually from closed, inactive to open and fully active 
conformation. The intermediate primed conformation can be activated by binding to 
ECM ligands (outside-in) or by recruitment of intracellular activator proteins to the 
cytoplasmic integrin tails (inside-out). Furthermore, integrins can also be inhibited by 
binding of integrin inhibitors to the cytoplasmic tails. Image modified from (Isomursu et 
al., 2019; Luo et al., 2007; Moreno-Layseca et al., 2019) 
Siiri Salomaa 
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Integrin inactivators are a diverse group of proteins that are known to bind both 
integrin α- and β-tails. For example, SHANK Associated RH Domain Interactor 
(SHARPIN) is known to bind to the integrin α-tail, whereas filamin is recruited to 
the β-tail (Rantala et al., 2011; Bouvard et al., 2013). In addition, SH3 and multiple 
ankyrin repeat domains protein 1 and 3 (SHANK1 and SHANK3) were recently 
shown to inhibit integrins indirectly by sequestering active Rap1 and limiting thereby 
talin-Rap1-RIAM-mediated integrin activation (Lilja et al., 2017). Taken together, 
thus far characterised integrin inactivators prevent the activation by limiting 
recruitment of integrin activators to the integrin β-tail (Bouvard et al., 2013; Pouwels 
et al., 2012). Interaction between integrin inhibitors and integrins may also be 
mechanosensitive, as for example interaction between filamin A and integrin β-tail 
has been shown to be regulated by actomyosin contractility and mechanical force 
(Ehrlicher et al., 2011; Pentikäinen and Ylänne, 2009). However, the role of 
mechanosignalling in regulation of integrin inhibitors have not been characterised in 
detail. 
2.1.2 Formation of adhesions and different adhesion types 
The formation of adhesions is initiated by integrin activation and ECM-binding. 
Active integrins recruit cytoplasmic proteins to form nascent adhesions. 
Furthermore, activation of integrins induces integrin clustering within the plasma 
membrane recruiting additional integrins to the developing adhesion (Lawson and 
Schlaepfer, 2012; Sun et al., 2014). Integrin-based adhesions can be divided into 
different subtypes based on their location, shape and size (Figure 2.) (Conway and 
Jacquemet, 2019; Gardel et al., 2010; Zaidel-Bar et al., 2004; Zamir et al., 1999). 
Nascent adhesions are early adhesions, which are smaller in size and relatively short-
lived. They are typically formed at the leading edge of a migrating cell or in 
proximity of protrusion sites (Zaidel-Bar et al., 2003). Nascent adhesions may 
mature into focal adhesions that are larger in size and more stable. Furthermore, they 
are more widely distributed and they are connected to contractile actin stress fibers 
(Oakes et al., 2012; Pasapera et al., 2010). Focal adhesions may further develop into 
elongated fibrillar adhesions depending on the ECM cues. Fibrillar adhesions are 
typically found in the cell center (Katz et al., 2000; Zaidel-Bar et al., 2004). Recently, 
filopodia adhesions have also been identified as their own adhesion type, as they 
have their distinct protein composition and localisation either at filopodia tip or along 
filopodia shaft. Moreover, filopodia adhesions can serve as precursors for nascent 
adhesion formation (Jacquemet et al., 2019). Early adhesion types, like for example 
filopodial and nascent adhesions, are often smaller in size and they have rapid 
turnover, whereas mature focal and fibrillar adhesions are larger in size, more stable 
and they persist for a longer time (Figure 2.) (Conway and Jacquemet, 2019; Gardel 
Review of the Literature 
 17 
et al., 2010; Choi et al., 2008; Webb et al., 2004; Doyle et al., 2012; Geiger and 
Yamada, 2011; Zamir et al., 1999). 
Importantly, different adhesion types have also distinctive protein composition 
and they associate with different signature proteins. Microscopy-based studies have 
shown that filopodia adhesions are enriched in Myosin-10 (Myo10), talin, kindlin 
and p130Cas (Jacquemet et al., 2019). Nascent adhesions are in turn characterised 
by talin and paxillin, and they contain lower levels of vinculin, FAK (Zaidel-Bar et 
al., 2003) and α-actinin (Choi et al., 2008). Furthermore, newly formed nascent 
adhesions lack tensin and zyxin, which are typically detected in more mature 
adhesion types. In focal adhesions, levels of vinculin, FAK, vasodilator-stimulated 
phosphoprotein (VASP), zyxin and α-actinin are increased compared to nascent 
adhesions. While lower levels of zyxin are observed already in focal adhesions 
(Zaidel-Bar et al., 2003), it is highly prominent in fibrillar adhesions together with 
tensin (Figure 2.) (Katz et al., 2000; Zaidel-Bar et al., 2004; Zamir et al., 1999). 
Both assembly and disassembly of focal adhesions needs to be carefully 
regulated, and dysregulation can lead to defective migration, e.g. loss of 
directionality, or problems with attachment and de-attachment (Pouwels et al., 
2013), or disturb several other signalling pathways, including cell proliferation and 
survival (Bouvard et al., 2013; Wozniak et al., 2004). Adhesion assembly can be 
promoted for example by integrin clustering (Wiseman et al., 2004), actin 
polymerization (Zaidel-Bar et al., 2004, 2003) and increase in tension and 
actomyosin contractility (Gardel et al., 2010; Oakes et al., 2012; Zaidel-Bar et al., 
2004). Dissassembly of focal adhesions can be triggered for example by protease 
activity (Franco et al., 2004), microtubules (Ezratty et al., 2005; Rafiq et al., 2019), 
cell division (Lock et al., 2018), integrin endocytosis (Moreno-Layseca et al., 2019) 
and focal adhesion kinase (FAK) signalling (Broussard et al., 2008; Tomar and 
Schlaepfer, 2009). Adhesion maturation is highly dependent on the actin 
cytoskeleton and the synergistic changes in the actin cytoskeleton and adhesion 
maturation and turnover are discussed in chapter 2.3.1.  
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Figure 2.  Four different adhesion types, their typical localisation and characteristic proteins that 
associate with each adhesion type. Image modified from (Conway and Jacquemet, 
2019; Gardel et al., 2010) 
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2.1.3 Composition of integrin-based cell adhesions 
Integrin-based adhesions are complexes that consist of tens to hundreds of associated 
proteins. The molecular composition of integrin-based adhesions have been 
investigated in several proteomic analyses studies (Horton et al., 2015; Zaidel-Bar 
et al., 2007). Different mass spectrometry screens have recognized altogether at least 
2412 proteins that associate with integrin-based adhesions indicating that the 
molecular composition of adhesions may vary a lot. However, a “consensus 
adhesome” of 60 proteins has been defined by comparing the different studies, and 
it is considered to represent the core components of integrin-based adhesions (Horton 
et al., 2015). 
Even though adhesions are composed of a large number of “adhesome” 
components, a general basic architecture has been proposed to be centered around a 
handful of key focal adhesion components (Kanchanawong et al., 2010).  
Futhermore, focal adhesions have been reported to consist of at least three conserved, 
regulatory layers that have partially overlapping components (Figure 3.). Integrin 
signalling layer is in close proximity of the plasma membrane and it contains for 
example paxillin and FAK. Integrin signalling layer is followed by an intermediate 
force-transduction layer that contains talin and vinculin that link integrins to the actin 
cytoskeleton. The innermost layer is an actin-regulatory layer containing both actin 
itself, and actin-regulatory proteins, such as α-actinin and zyxin (Kanchanawong et 
al., 2010; Stubb et al., 2019). 
On top of the well-established adhesion constituents, the exact focal adhesion 
composition is regulated at least by the ECM ligands (Humphries et al., 2009), the 
integrin heterodimers involved (Bidone et al., 2019; Schiller et al., 2013), integrin 
activation status (Byron et al., 2015), adhesion size (Gardel et al., 2010; Zaidel-Bar 
et al., 2003), mechanical properties and actomyosin contractility (Choi et al., 2008; 
Oakes et al., 2012; Vicente-Manzanares et al., 2009), the maturation time (Horton et 
al., 2015; Gardel et al., 2010) and cell type (Conway and Jacquemet, 2019; Zaidel-
Bar et al., 2004, 2003). 
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Figure 3.  Integrin-based adhesions have three characteristic regulatory layers: integrin signaling 
layer, force transduction layer and actin-regulatory layer. Each of these layers have 
characteristic protein components that may partially overlap between layers. Image 
adapted from (Kanchanawong et al., 2010; Stubb et al., 2019) 
Review of the Literature 
 21 
2.2 The actin cytoskeleton 
The cytoskeleton maintains cell shape, mediates intracellular transport and is 
essential for cell migration. The cytoskeleton consists of three main components; 
microtubules, intermediate filaments and actin. Microtubules are composed of α- and 
β-tubulins, which give rise to long and thick, cylindrical structures that have an 
important role in cell division and organelle transportation. Intermediate filaments 
are highly cell type specific structures that are composed of various different 
proteins, which are divided into four categories; keratins, vimentin and vimentin-
related filaments, nuclear lamins and neurofilaments. However, their shared feature 
in different cell types and tissue are to provide mechanical support to the cell and 
protect it against external stresses. In this thesis, the focus will be on the actin 
cytoskeleton that is essential for cell morphology and movement of cells (Alberts et 
al., 2009; Hohmann and Dehghani, 2019). Actin is involved in plethora of cellular 
processes as it can both maintain the existing cytoskeletal structures and form 
protrusions towards any certain direction depending on the situation. Furthermore, 
actin-mediated changes in cells modulate polarity of the cell and cellular structures, 
transmit mechanical forces, alter cell shape, regulate endocytosis and mitochondrial 
dynamics, and mediate intracellular transport and transcription. Thereby, disturbed 
or abnormal regulation of the actin cytoskeleton associates with many developmental 
and physiological disorders, including cancer, neurodevelopmental disorders and 
myofibrillar myopathies (Alberts et al., 2009; Blanchoin et al., 2014; Hohmann and 
Dehghani, 2019).  
2.2.1 Actin-binding proteins modulate the actin cytoskeleton 
Actin is a 42 kilodalton (kDa) protein, which is one of the key components in the 
cytoskeleton of a cell. It can exist in two different forms: monomeric globular actin 
(G-actin) and linear polymeric, filamentous actin (F-actin), which forms double-
helical structures (Holmes et al., 1990; Oda et al., 2009). Actin filaments are 
regulated in three central steps: nucleation, elongation and depolymerisation, and the 
process is powered by adenosine triphosphate (ATP) hydrolysis. The monomeric G-
actin undergoes constant turnover between adenosine diphosphate (ADP)- and ATP-
bound states. ATP-bound G-actin can form more stable oligomers via non-covalent 
interactions. These oligomers can form an actin nucleus, which is a stable multimer 
of G-actin that can serve as a precursor for actin polymersation (Pollard and Borisy, 
2003; Xue and Robinson, 2013). Importantly, actin filaments are polar structures, 
and they have a fast-growing barbed end, and a slow-growing pointed end (Figure 
4.). The ATP-bound G-actin monomers are added to the barbed end, but the ATP is 
hydrolysed into ADP towards the pointed end of an actin filament reducing the 
strength of the interaction between actin monomers and making it more prone to 
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depolymerisation (Pollard and Borisy, 2003; Xue and Robinson, 2013). Moreover, 
the dissociated ADP-bound actin monomers can be recharged through a nucleotide 
exchange back to ATP-bound actin monomers and added back to the barbed end. 
This constant addition of ATP-bound G-actin to the barbed end and dissociation of 
ADP-bound monomers from the pointed end forms a cycle called actin treadmilling 
(Figure 4.). Furthermore, this cycle maintains the cellular G-actin pool, that is 
essential for rapid re-organization of the actin cytoskeleton (Carlier and Shekhar, 
2017; Suarez and Kovar, 2016).  
Importantly, the actin cytoskeleton undergoes continuous reorganization, and it 
responds to both biochemical and mechanical signals (Blanchoin et al., 2014; 
Hohmann and Dehghani, 2019). The actin assembly and disassembly, formation and 
maintenance of the various actin structures and contacts between the actin 
cytoskeleton and other cellular structures require interaction between actin and 
multiple other proteins. Thereby, several different actin-binding proteins (ABPs) are 
needed to modulate the actin cytoskeleton. These ABPs have distinct functions, and 
they are divided into four sub-groups in this thesis: actin filament length regulators, 
actin-bundling proteins and actin crosslinkers, proteins that link actin to membranes 
and other cytoskeletal strucures, and contractility-related proteins. This thesis will 
introduce some of the major ABPs from each sub-group, but also plenty of other 
factors participate in regulation of actin dynamics. 
Figure 4.  Actin treadmilling is a continuous process in which ATP-bound G-actin monomers are 
added to the barbed end of an actin filament, and ADP-bound G-actin monomers are 
dissociated from the pointed end. Pi = inorganic phosphate. Picture modified from 
Alberts et al., 2004. 
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2.2.1.1 The Arp2/3 complex nucleates branched actin filaments 
Actin polymerization occurs naturally as such, but the process is very slow and actin 
nucleators and actin elongators are needed to enhance the assembly rate. The actin-
related protein 2/3 (Arp2/3) complex is the major actin nucleator. It is found in all 
cell types where it helps to overcome the kinetic barriers of actin polymerization 
(Insall and Machesky, 2009; Rotty et al., 2013; Pollard, 2007). The Arp2/3 complex 
consists of seven subunits – Arp2, Arp3 and ArpC1-5 and all of its subunits are 
required to form a stable complex. Arp2 and Arp3 are the catalytic subunits, while 
ArpC1-5 act as stabilizers and scaffold the protein complex (Rotty et al., 2013). 
Moreover, Arp3 (Jay et al., 2000), ArpC1 (Abella et al., 2016) and ArpC5 (Millard 
et al., 2003) have been reported to have several isoforms mammalians, and different 
ArpC3 isoforms have been recognized in Drosophila melanogaster (Hudson and 
Cooley, 2002). The significance of the different isoforms has not been extensively 
studied, but it has been shown that some of the different isoforms have distinct cell 
type and tissue specific expression profiles (Millard et al., 2003; Jay et al., 2000). 
Furthermore, the isoform composition may also affect actin polymerization 
efficiency and how prone the produced actin filaments are to disassemble (Abella et 
al., 2016). 
The Arp2/3 complex binds to the side of an existing actin filament (a mother 
filament), which triggers a conformational change in the Arp2/3 complex bringing 
the catalytic subunits Arp2 and Arp3 in close proximity. Importantly, the rearranged 
catalytic subunits resemble the barbed end of an actin filament promoting thereby 
recruitment of ATP-loaded G-actin monomers to the growing filament (Krause and 
Gautreau, 2014; Rotty et al., 2013) initiatiating formation of a new actin filament (a 
daughter filament) at a distinctive ~70⁰ angle (Pollard, 2007). 
The Arp2/3 complex has low intrinsic activity as such, and other proteins are 
needed to promote its activity. These activators are commonly known as nucleation 
promoting factors (NPFs), and they are divided into two classes: type I NPFs, which 
bind actin monomers, and type II NPFs, which bind actin filaments, in addition to 
binding to the Arp2/3 complex (Helgeson and Nolen, 2013; Machesky and Insall, 
1998; Rotty et al., 2013). Type I NPFs have a characteristic verprolin homology, 
central acidic (VCA) domain, which binds the actin monomers and is required to 
promote the Arp2/3 complex activation efficiently (Kelly et al., 2006). The well-
established members of type I NPFs include the Wiscott-Aldrich syndrome protein 
(WASP), suppressor of cAR (SCAR) and the WASP-family verprolin-homologous 
protein (WAVE) complex (Insall and Machesky, 2009; Machesky and Insall, 1998; 
Paavilainen et al., 2004; Rotty et al., 2013). Taken together, type I NPFs promote 
Arp2/3 activity by bringing together the Arp2/3 complex, a mother filament and actin 
monomers (Paavilainen et al., 2004; Pollard, 2007; Winder and Ayscough, 2005). 
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Type II NPFs have only low nucleation promoting activity compared to the type I 
NPFs as they lack the full VCA domain, but they are thought to have other functions 
that promote actin branching (Paavilainen et al., 2004; Rottner et al., 2017; Rotty et 
al., 2013). The most well-characterised type II NPF is cortactin (Helgeson and Nolen, 
2013; Weed et al., 2000), which promotes formation of an actin branch by dislocating 
VCA-containing type I NPF from the Arp2/3 complex, stabilizing the growing branch 
and preventing debranching (Helgeson and Nolen, 2013; Weaver et al., 2001). Another 
type II NPF, actin-binding protein (Abp1), has been shown to promote Arp2/3-
mediated actin nucleation through stabilizing branches by protecting filaments from 
branching-inhibiting glial maturation factor (GMF) (Gao et al., 2019). However, type 
II NPFs remain less well-characterised compared to type I NPFs.  
Branched actin produced by the Arp2/3 complex is encountered in adherens 
junctions, endosomes, phagosomes and at the leading edge of migrating cells (Rotty et 
al., 2013). In this thesis the focus will be on the leading edge. Importantly, the Arp2/3-
mediated polymerization of branched actin at the leading edge pushes the plasma 
membrane forward creating a wide, protrusive front that leads the cell migration. 
Thereby, the Arp2/3 complex has a pivotal role in promoting directional cell migration 
(Krause and Gautreau, 2014; Pollard and Borisy, 2003; Suraneni et al., 2012).  
2.2.1.2 Formins elongate newly synthesized actin filaments 
In addition to the Arp2/3 complex, other proteins can also nucleate actin filaments. 
While the Arp2/3 complex catalyses formation of branched actin, the formin protein 
family has an important role in nucleation and elongation of linear actin filaments 
(Breitsprecher and Goode, 2013; Higgs, 2005; Kovar, 2006). However, the exact 
mechanism how formins promote actin nucleation has not been unravelled in full 
detail, (Breitsprecher and Goode, 2013; Paul et al., 2008; Vavylonis et al., 2006), but 
they have been suggested to bind and stabilize actin monomers together forming 
thereby an initial actin nucleus (Pollard, 2007). Most famously, formins elongate 
actin filaments by adding actin monomers to the barbed end and by preventing 
binding of elongation terminating capping proteins (Paul et al., 2008; Pruyne et al., 
2002; Vavylonis et al., 2006).  
Formins are a large and heterogeneous family that has been shown to be encoded 
by at least 15 genes in mammals alone, and they have tissue- and cell type-specific 
expression patterns (Krainer et al., 2013). While formins are a diverse protein family, 
their function is mechanistically similar and they share highly conserved formin 
homology 1 (FH1) and formin homology 2 domains (FH2), which are sided by more 
various regulatory domains (Kovar, 2006). Importantly, formins form homodimers 
through FH2 domain adapting thereby a characteristic donut-shaped conformation (Xu 
et al., 2004), in which both subunits can bind two actin monomers (Pruyne et al., 2002). 
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Furthermore, FH2 domain binds actin, while FH1 domain may bind actin monomer 
binding protein profilin that brings ATP-bound actin monomers to the barbed end of 
an actin filament (Paul et al., 2008; Pruyne et al., 2002; Vavylonis et al., 2006). Some 
formins, such as Diaphanous-related formins, are regulated by autoinhibition, and they 
have a characteristic diaphanous inhibitory domain (DID) and diaphanous auto-
regulatory domain (DAD) (Breitsprecher and Goode, 2013; Higgs, 2005). In addition, 
these autoinhibited formins have a GTPase-binding domain (GBD), which is a binding 
site for different Rho GTPases (Otomo et al., 2005; Rose et al., 2005). Autoinhibitory 
mechanism of formins is elementary, as for example point mutations that disrupt 
function of the DID and DAD domains of inverted formin 2 (INF2) lead to 
uncontrolled actin filament elongation and associate with Charcot-Marie-Tooth 
disease and focal segmental glomerulosclerosis (A et al., 2019). 
In addition to having tissue- and cell type specific expression patterns (Krainer 
et al., 2013), distinct formins are also known to associate with different cellular actin 
structures. For example, Diaphanous-related formin dDia2 (Schirenbeck et al., 2005) 
and formin-like protein 2 (FMNL2)  (Block et al., 2012) have been shown to promote 
filopodia formation (Schirenbeck et al., 2005), mammalian formin mDia1 catalyses 
formation of dorsal actin stress fibers (Hotulainen and Lappalainen, 2006) and INF2 
has been shown to associate with endoplasmatic reticulum (Chhabra et al., 2009) and 
promote thereby mitochondrial dynamics (Chakrabarti et al., 2018). 
2.2.1.3 Cofilin and other actin-severing proteins promote actin 
disassembly 
In general, actin polymerisation at the barbed end occurs faster than dissociation of 
G-actin monomers at the pointed end. Therefore, different ABPs inhibit actin 
polymerisation and filament elongation, and induce actin depolymerisation (Dos 
Remedios et al., 2003). Disassembly of actin filaments can be induced by actin-
severing proteins, such as cofilin-1. The actin depolymerizing factor (ADF)/cofilin 
family proteins are the best-characterised proteins that mediate actin turnover and 
disassembly. In mammalians, the ADF/cofilin family has been reported to consist of 
three proteins: ADF (also known as destrin), cofilin-1 and cofilin 2 (Maciver and 
Hussey, 2002), which have tissue and cell type specific expression profiles. Cofilin-
1 is found in most cells, while ADF is mainly expressed neuronal and epithelial cells 
(Vartiainen et al., 2002). Cofilin-2 is expressed in muscle tissues, and it is also less 
efficient in depolymerising actin filaments compared to ADF and cofilin-1 
(Vartiainen et al., 2002). Furthermore, ADF and cofilin-1 can compensate each other 
in some extent (Hotulainen et al., 2005) and they have higher affinity for ADP-bound 
actin monomers, but cofilin-2 can also interact with ATP-bound actin monomers 
with higher affinity (Kremneva et al., 2014). ADF/cofilin family proteins can both 
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severe actin filaments and promote dissociation of ADP-bound G-actin monomers 
from the pointed (Kanellos and Frame, 2016; Paavilainen et al., 2004). As 
ADF/cofilin dissociates actin monomers from the pointed end of an actin filament, 
the released monomers can be re-charged with ATP and recycled to the barbed end 
where the filament grows faster maintaining the dynamic actin turnover. 
Furthermore, this treadmilling may promote membrane protrusion and cell 
migration, as the fast-growing end pushes the plasma membrane forward (Kanellos 
and Frame, 2016). Indeed, ADF and cofilin-1 knockdown cells have been shown to 
migrate poorly (Hotulainen et al., 2005). 
Actin filament length can also be modulated by different capping proteins and 
actin monomer binding proteins. Capping proteins that bind to the growing barbed 
end block addition of new G-actin monomers, and inhibition of capping proteins 
leads to aberrant lamellipodia formation and induced filopodia formation (Mejillano 
et al., 2004). Some barbed end-capping proteins, such as gelsolin, can also severe 
actin filaments and induce actin depolymerisation (Winder and Ayscough 2005). 
Therefore, capping proteins participate in regulation of the cellular G-actin monomer 
pool. In addition, cytoplasmic actin monomer binding proteins, such as twinfilin, can 
suppress actin polymerization by sequestering free actin monomers and/or by 
keeping them in GDP-loaded state (Xue and Robinson, 2013; Palmgren et al., 2002). 
2.2.1.4 Actin-bundling proteins and crosslinkers organize higher-order 
actin structures 
Proteins that crosslink and bundle simple actin filaments are important in creating 
higher-order F-actin structures. Actin-bundling proteins bring actin filaments together 
and align them in a parallel manner, while crosslinkers organise actin filaments 
together in more various ways, including for example centripetal or branched 
alignment. In order to bundle or crosslink actin filaments, a protein needs to have either 
two or more, distinct actin-binding sites or it needs to dimerize or oligomerize (Winder 
and Ayscough, 2005). For example, actin bundling protein fascin has two actin-
binding sites (Jansen et al., 2011), whereas another actin bundling protein α-actinin 
dimerises in order to bundle filaments (Meyer and Aebi, 1990). Also actin crosslinkers 
come in various shapes and sizes, as they organize filaments in various structures. For 
example, a large actin crosslinker, spectrin, has several actin-binding sites, whereas 
transgelin, a small actin crosslinker, is known to dimerise to crosslink actin (Winder 
and Ayscough, 2005). Different actin bundling proteins and actin crosslinkers have an 
important role in formation of distinct cellular actin structures. For example, actin 
bundling proteins have an important role in assembly of actin stress fibers and 
filopodia, whereas actin crosslinkers organize dense, branched actin network at the 
leading edge (Matsudaira, 1994; Tseng et al., 2005). 
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2.2.1.5 Proteins that link actin to other cytoskeletal structures, the 
plasma membrane and membrane proteins 
The actin cytoskeleton acts as a mechanical framework and scaffold for many other 
proteins. Importantly, many proteins bind to actin without having actin modulation 
as their primary function. These proteins include for example proteins that create 
anchorage to membrane proteins and directly to the plasma membrane, and proteins, 
which link actin to other cytoskeletal elements. While the actin cytoskeleton forms 
an important part of the cytoskeleton, it is linked to other cytoskeletal elements, 
namely microtubules and intermediate filaments, through other proteins. For 
example, plectin links actin filaments to both microtubules and intermediate 
filaments (Winder and Ayscough, 2005). In addition, the actin cytoskeleton is 
connected to the plasma membrane via linker proteins, such as Myosin 1 and ezrin-
radixin-moesin (ERM) family proteins (McClatchey, 2014). Furthermore, actin is 
also indirectly linked to transmembrane proteins integrins through adhesion proteins 
talin and vinculin (Geiger et al., 2001; Humphries et al., 2007).  
2.2.1.6 Contractility-related proteins 
In order for a cell to move or divide, actin filaments need to be able to transmit forces 
and contract. While actin forms the base of the “skeleton and muscles” needed for a 
cell to move and change shape, it needs ABPs in order to contract and create force. 
Importantly, myosin family of motor proteins are crucial in generation of force and 
movement. There are roughly 20 classes of different myosins and they differ in their 
structure and specified functions. Two-headed myosin II has a pivotal role in 
function of the actin stress fibers, where it participates in creation of contractile 
forces and tension. In addition, myosins use actin as a route for moving different 
cargo ranging from vesicles to other proteins. Myosin II decorates actin filaments in 
a bipolar manner and it contracts the filaments powered by ATP hydrolysis 
(Tojkander et al., 2011, 2015; Vicente-Manzanares et al., 2009). In addition to 
myosins, several different proteins and protein families have been observed to 
modulate contractility of F-actin. For example actin-bundling proteins, such as α-
actinin, have an important role in stress fibers, that are major contractile actin 
structures of mesenchymal cells (Tojkander et al., 2012). 
2.2.2 Actin structures of a cell 
The actin cytoskeleton acts as a functional scaffold for many cellular processes, and 
it has a crucial role in cell morphogenesis and intracellular architecture. As actin 
participates in plethora of cellular events, also cellular actin structures are diverse. 
Here, the focus will be on actin structures that are needed for integrin-mediated cell 
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adhesion and lamellipodial (also known as mesenchymal) cell migration in 2D 
environments. Importantly, polarization of a cell is a prerequisite for cell migration. 
The front of a migrating cell is referred to as the leading edge, which is the protrusive 
front of the cell, and the back of a cell is called the trailing edge (Figure 5.) (Conway 
and Jacquemet, 2019; Petrie and Yamada, 2012). Whilst this chapter introduces actin 
structures characterised in 2D environments, it is important to acknowledge that 
these structures are also adapted in 3D environments (Caswell and Zech, 2018). 
 
Figure 5.  A simplistic illustration describing different actin structures typically found in a 
mesenchymal cell in 2D. 
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2.2.2.1 Filopodia are thin protrusions that probe the environment 
Filopodia, also known as microspikes, are actin-rich, finger-like protrusions at the 
cell front that sense the surrounding environment (Figure 5.). In normal conditions, 
filopodia formation has a role in neuronal growth cone guidance, fusion of epithelial 
sheets and embryogenesis, but they also have a central role in some pathological 
conditions, such as cancer cell migration (Jacquemet et al., 2015; Mattila and 
Lappalainen, 2008; Gallop, 2020). In addition to interacting with the ECM, filopodia 
have also been shown regulate directional cell migration through sensing 
chemokines (Boer et al., 2015; Meyen et al. 2015). Therefore, findings from both 
developmental (Boer et al., 2015; Meyen et al. 2015) and cancer studies highlight 
the role of filopodia in guiding cell migration also in 3D environments (Caswell and 
Zech, 2018; Jacquemet et al., 2015).The length of a filopodium varies a lot based on 
a cell type and the cellular context. Filopodia consist of parallel actin bundles, that 
are packed tightly together by actin-bundling proteins, such as fascin (Faix et al., 
2009; Mattila and Lappalainen, 2008; Vignjevic et al., 2006). Several different 
mechanisms have been proposed for filopodia formation. In the de novo nucleation 
model, filopodia are initiated by formins (Faix et al., 2009; Kage et al., 2017; Yang 
and Svitkina, 2011; Mellor, 2010). In the convergent elongation model, actin 
filaments of the filopodia originate from the lamellipodial actin network, and are 
thereby originally initiated by Arp2/3-mediated actin nucleation and branching 
(Korobova and Svitkina, 2008; Svitkina et al., 2003). However, neither of these 
mechanisms seems to be essential, as downregulation or knockout of the Arp2/3 
complex is known to induce formation of filopodia while the lamellipodia formation 
is reduced showing that Arp2/3 mediated actin nucleation is not necessary for 
formation of filopodia. Furthermore, filopodia are also observed after silencing or 
knockout of formins (Rottner et al., 2017; Steffen et al., 2013; Wu et al., 2012). 
Taken together, these findings indicate that there are multiple, mutually exclusive 
ways how filopodia can be formed, and the filopodia formation mechanisms may be 
cell type-specific (Young et al., 2015). 
2.2.2.2 Lamellipodia consists of branched actin network 
A lamellipodium is a wide, veil-like zone of branched actin at the leading edge of a 
cell (Figure 5.). Depending on the cell type, lamellipodium length has been reported 
to be approximately 1-5 µm starting from the leading edge (Ponti et al., 2004; Small 
et al., 2002). Furthermore, the composition and stiffness of the surrounding 
environment and the ECM also affect lamellipodia formation. Strong lamellipodia 
are formed especially in cells migrating on rigid 2D surfaces (Krause and Gautreau, 
2014; Small et al., 2002; Wu et al., 2012). In 3D matrices, lamellipodia are typically 
smaller, more elongated and less uniform in shape (Caswell and Zech, 2018; Petrie 
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et al., 2012). In addition to lamellipodia, cells utilize also other types of leading edge 
structures that will be discussed further in chapter 2.3.2. 
Importantly, formation of the lamellipodial branched actin network is dependent 
on the Arp2/3 complex and its activators, NPFs (Krause and Gautreau, 2014; Rotty 
et al., 2013; Suraneni et al., 2012; Wu et al., 2012). However, also other ABPs 
regulate the lamellipodial actin network. For example, actin crosslinkers, such as 
filamin, assemble the branched actin network (Ydenberg et al., 2011), capping 
proteins regulate the length of the formed actin filaments (Akin and Mullins, 2008) 
and actin disassembly factors, such as cofilin-1, maintain actin turnover and thereby 
modulate protrusion formation (Hotulainen et al., 2005; Kanellos and Frame, 2016). 
In fact, the rate of lamellipodial actin assembly is dependent on available G-actin 
pool (Rottner et al., 2017).  
Growing lamellipodia extends towards the plasma membrane generating pushing 
forces and promoting membrane protrusion. However, the Arp2/3-dependent actin 
branching has a poor efficiency in generating mechanical force and the rate of actin 
polymerization at the lamellipodia edge is not proportional to protrusion efficiency 
or force generation. Importantly, formin-induced actin filaments have been observed 
to induce force generation at the lamellipodia highlighting the role of other ABPs in 
regulation of lamellipodial dynamics (Kage et al., 2017). 
A lamellipodium is followed by a lamellum, which is a zone of densely packed 
actin network and curved, contractile actin stress fibers that are aligned parallel to 
the leading edge (Figure 5.). Lamella are created by condensation of lamellipodial 
branched actin through actin retrograde flow (discussed in chapter 2.3.1). 
Importantly, lamella has a far greater force generation capability compared to 
lamellipodia as it contains contractile actin structures (Ponti et al., 2004; Giannone 
et al., 2004; Mendoza et al., 2015; Burnette et al., 2011).  
2.2.2.3 Actin-associated motor proteins generate force and increase 
contractility of actin stress fibers 
Actomyosin is the basis of contractile structures, such as myofibrils of muscles, 
cytokinetic ring during cell division and stress fibers of non-muscle cells (Michelot 
and Drubin, 2011). Importantly, actin stress fibers (Figure 5.) have a central role in 
cell adhesion, cell migration, force generation and cell morphogenesis. Stress fibers 
are thick bundles of multiple actin filaments that have been reported to consist of up 
to 30 actin filaments (Cramer et al., 1997). Contractility-associated ABPs, such as as 
non-muscle myosin II, have a crucial role in formation and function of stress fibers 
as they generate force along the stress fibers (Vicente-Manzanares et al., 2009; 
Tojkander et al., 2011). In fact, stress fibers appear to be dependent on tension and 
contraction as inhibition of myosin II leads to disassembly of stress fibers (Smith et 
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al., 2010; Humphries et al., 2007; Burridge and Guilluy, 2016). However, while actin 
and myosin II are the central components of stress fibers, they also employ a variety 
of other ABPs. For example, α-actinin is known to bundle and crosslink the parallel 
actin filaments together (Pellegrin and Mellor, 2007; Meyer and Aebi, 1990) and 
formins have been reported to nucleate and elongate stress fibers (Watanabe et al., 
1999; Tojkander et al., 2011; Hotulainen and Lappalainen, 2006). In addition to 
ABPs, actin stress fibers also associate with several focal adhesion-associated 
proteins, such as vinculin and talin. Importantly, focal adhesion-related proteins may 
modulate stress fiber assembly and their turnover (Choi et al., 2008; Chrzanowska-
Wodnicka and Burridge, 1996; Pasapera et al., 2010). 
Prominent stress fibers are not typical for all cell types. In cultured mammalian 
cells, strong stress fibers are found especially in fibroblasts, endothelial cells and 
some cancer cell lines. The type of stress fibers may also vary a lot: in highly motile 
cells, stress fibers are typically more dynamic and thinner, whereas in non-motile 
cells they can be very stable and thick (Pellegrin and Mellor, 2007; Tojkander et al., 
2012). Furthermore, extracellular cues including both biochemical and mechanical 
signals modulate stress fiber number, structure and organization. Importantly, stress 
fibers are most abundant in tissues and localizations where they encounter high 
mechanical stresses. Culture on rigid 2D surfaces, such as typical cell culture plastic, 
may induce stress fiber number and thickness, and in turn, cells grown on softer 
substrates have more delicate stress fibers (Discher et al., 2005). Taken together, 
these observations highlight the role of mechanosensing in regulation of stress fibers. 
Consistently, experiencing mechanical stress, such as fluid shear stress, may induce 
stress fiber formation in endothelial cells (Malek and Izumo, 1996; Noria et al., 
2004). Moreover, stress fibers are also observed in 3D environments (Petrie et al., 
2012; Gateva et al., 2014).  
2.2.2.3.1 Stress fibers can be divided into four different subtypes 
Stress fibers exist in multiple forms, and the distinct types of stress fibers associate 
differently with focal adhesions and localize differently within a cell. Stress fibers 
are divided into three or four subcategories, depending on the source (Figure 6.). 
Dorsal stress fibers originate from the leading edge and they are oriented radially to 
the edge. Importantly, dorsal stress fibers are linked to a focal adhesion from one 
end, and they do not typically contain contractility-inducing myosin II (Hotulainen 
and Lappalainen, 2006; Tojkander et al., 2011, 2012). Dorsal stress fibers are 
followed by curved transverse arcs that are a part of lamella and originate from 
lamellipodia. Transverse arcs move towards the center and posterior part of a 
migrating cell due to actin retrograde flow. Transverse arcs contain myosin II and 
they are thereby contractile. However, transverse arcs are not connected to focal 
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adhesions to begin with, but they may fuse together with dorsal stress fibers and 
create additional contacts to focal adhesions maturing eventually into ventral stress 
fibers (Ponti et al., 2004; Burnette et al., 2011; Hotulainen and Lappalainen, 2006). 
Ventral stress fibers are anchored to focal adhesions from both ends and they occur 
typically in the central and posterior parts of a cell (Pellegrin and Mellor, 2007; 
Burridge and Guilluy, 2016; Tojkander et al., 2012). Perinuclear actin cap has been 
proposed to be a fourth subtype of stress fibers. It resembles structurally ventral 
stress fibers as it also consists of actomyosin bundles that are linked to focal 
adhesions from both ends. However, perinuclear actin cap reaches above the nucleus 
and it is thought to provide mechanical protection to the nucleus and regulate its 
shape and position. The perinuclear actin cap may also regulate nuclear shape in 
interphase cells, but it has also been proposed to participate in mechanotransduction 
between cell’s environment and the nucleus (Khatau et al., 2009). 
 
Figure 6.  Actin stress fibers can be divided into four distinct categories: dorsal stress fibers, 
transverse arcs, ventral stress fibers and perinuclear actin cap. Each of these stress 
fiber types has its characteristic localization and association with adhesions.  
2.2.2.4 The actin cortex regulates cell shape and membrane tension 
Actin filaments are most concentrated just beneath the plasma membrane where they 
form a thin layer called the actin cortex, which is the main regulator of cell shape 
(Figure 5.) (Chalut and Paluch, 2016; Chugh and Paluch, 2018). Cortical actin 
filaments form a densely packed meshwork, which is organized by actin crosslinkers 
(e.g. α-actinin), myosin motor proteins (e.g. myosin II) and proteins that anchor the 
actin filaments to the plasma membrane (e.g. ERM family proteins) (Salbreux et al., 
2012; McClatchey, 2014; Chugh and Paluch, 2018). The cortical actin network is 
generated at least by the Arp2/3 complex and formin mDia1 (Chugh and Paluch, 
2018). The actin cortex undergoes a constant turnover, which allows the cell to adapt 
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to external cues and stresses. Thereby, the actin cortex can accommodate rapid, 
mechanical changes in the cell shape in response to different stimuli. Furthermore, 
the actin cortex regulates membrane tension, which has an important role in various 
cellular processes, including cell migration (Charras and Paluch, 2008; Sanz-Moreno 
and Marshall, 2010), cell division and tissue morphogenesis (Chalut and Paluch, 
2016; Salbreux et al., 2012). Local plasma membrane-actin cortex detachment or 
disassembly of the cortical actin may give rise to bleb formation, which can be used 
as a leading edge structure instead of lamellipodia in different migration modes 
(Fackler and Grosse, 2008; Diz-Muñoz et al., 2016; Charras and Paluch, 2008), 
which will be discussed further in Chapter 2.3.2. 
2.2.2.5 Podosomes and invadopodia create contacts to the ECM  
Podosomes and invadopodia are actin-rich, adhesive structures that cells use to 
interact with the surrounding ECM. While podosomes are structures that occur in 
normal, healthy cells, such as macrophages, invadopodia are typical for cancer cells 
and they are induced through activation of Src family kinases (Kelley et al., 2010; 
Tehrani et al., 2007) and protein kinase C (PKC) (Bowden et al., 1999; Murphy and 
Courtneidge, 2011). Podosomes have an actin core, which consists of branched actin 
filaments surrounded by an integrin-based ring structure (Hoshino et al., 2013; 
Branch et al., 2012). Formation of the branched filaments is dependent on Arp2/3 
activity, which is typically activated by WASP, an actin-regulator specifically found 
in podosomes, but not focal adhesions or invadopodia (Hoshino et al., 2013; Murphy 
and Courtneidge, 2011). In addition, the ring of integrins and other adhesion-related 
proteins, such as vinculin and talin, which frames the actin core, is specific to 
podosomes. A cap in the cytosolic part of podosomes contains formins and organizes 
longer actin filaments that extend towards the ring and link to integrins thereby 
allowing podosomes to act as mechanosensors (Hoshino et al., 2013; Murphy and 
Courtneidge, 2011; Branch et al., 2012). 
The actin core of invadopodia is also dependent on the Arp2/3 complex and its 
activator N-WASP (Oser et al., 2009). The actin network is anchored to the membrane 
and adhesion proteins similarly to podosomes, the growing invadopodium maybe 
dissociated from actin polymerization before it matures altering turnover rate (Murphy 
and Courtneidge, 2011). Both Arp2/3 activity and formins are required for the growth 
of invadopodia and formation of protrusions. Integrins have a pivotal role in 
invadopodia formation, as they often create the first contact between the cell and the 
ECM (Linder et al., 2011; Branch et al., 2012; Murphy and Courtneidge, 2011), 
however invadopodia lack a clear spatially defined integrin ring structure and may be 
more puncta-like (Clark and Weaver, 2008). Importantly, invadopodia are protrusions 
that cells use especially in context of cancer to establish connections with the ECM 
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and to remodel it. For example, invadopodia utilize matrix metalloproteases (MMPs) 
to degrade the surrounding ECM and to promote cancer cell invasion (Linder, 2007; 
Linder et al., 2011; Basbaum and Werb, 1996). Taken together, the protrusiveness and 
lifetime are the main difference between podosomes and invadopodia - podosomes are 
short lived structures (minutes) characteristic to migrating cells and invadopodia are 
long lived matrix degrading structures that can persist for hours (Li et al., 2010; 
Basbaum and Werb, 1996). 
2.3 At the interface of cell adhesion and the actin 
cytoskeleton 
There is an enormous amount of crosstalk between cell adhesion and the actin 
cytoskeleton. Importantly, they function in an orchestrated manner in many 
biological processes, such as cell migration and tissue maintenance (Discher et al., 
2005; Geiger et al., 2001). In this chapter, the interdependent function of cell 
adhesion and actin dynamics will be discussed using cell migration as an example.  
2.3.1 The actin retrograde flow and adhesion maturation 
Actin retrograde flow comprehends a continuous cycle driven by actin 
polymerisation and actomyosin contractility (Vallotton et al., 2004). In this cycle 
actin is polymerized at the leading edge, from which it flows towards the cell body 
forming lamella and stress fibers, which in turn connect to focal adhesions increasing 
contractility and eventually translocate closer to the trailing edge of the cell until 
adhesions at the trailing edge are disassembled (Swaminathan et al., 2017). 
Therefore, actin retrograde flow has a crucial role in adhesion maturation. As 
described in chapter 2.1.2, adhesions can be divided into at least four different 
subtypes. The initial adhesions are smaller filopodia and/or nascent adhesions, which 
recruit other adhesion proteins, such as talin and vinculin, while they undergo 
maturation (Conway and Jacquemet, 2019). Furthermore, connection to talin and 
vinculin links adhesions to the actin cytoskeleton and importantly, to contractile 
actin stress fibers. These actomyosin bundles transmit increased tension and forces 
to integrin-based adhesions promoting their maturation into focal and fibrillar 
adhesions changing their alignment and orientation. Taken together, actin retrograde 
flow is dependent on actin polymerization and contractility, and it regulates adhesion 
formation and maturation (Ponti et al., 2004; Schwarz and Gardel, 2012; 
Swaminathan et al., 2017; Alexandrova et al., 2008; Burnette et al., 2011). 
Engagement with the actin cytoskeleton has a critical role in regulation of the 
morphological and compositional maturation of adhesions. Formation of early 
filopodia adhesions is initiated by integrin-ECM engagement at the filopodia tip. 
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Paxillin is recruited to tips of stable filopodia, from where it translocates to filopodia 
shafts and starts forming adhesion-like clusters. These clusters may give rise to 
nascent and focal adhesions when lamellipodia advances (Jacquemet et al., 2019). 
So far, filopodia adhesions remain less well characterised compared to other 
adhesion types. Formation of nascent adhesions is driven by actin polymerization at 
the leading edge, but it does not depend on myosin II-mediated contraction (Choi et 
al., 2008; Vicente-Manzanares et al., 2009). Moreover, lamellipodial protrusion 
dynamics have been shown to regulate protein composition and stabilization of 
nascent adhesions as inhibition or arrest of lamellipodial protrusion triggers zyxin 
recruitment to nascent adhesions inducing adhesion growth and focal adhesion 
maturation (Zaidel-Bar et al., 2003).  
Mature focal adhesions are linked to contractile actomyosin stress fibers and 
increased actomyosin contractility promotes adhesion growth and maturation 
(Chrzanowska-Wodnicka and Burridge, 1996; Humphries et al., 2007; Vicente-
Manzanares et al., 2009; Choi et al., 2008). Importantly, myosin II-activity has been 
shown to promote the compositional maturation of adhesions by promoting vinculin 
recruitment to adhesions by inducing FAK-mediated paxillin phosphorylation 
(Pasapera et al., 2010). Furthermore, vinculin recruitment induces focal adhesion 
growth by promoting clustering of activated integrins and slowing down integrin 
turnover (Humphries et al., 2007).  
Focal adhesion maturation is a mechanosensitive process, but while increased 
tension and contractility clearly promote focal adhesion maturation, myosin II 
activity is not absolutely essential for focal adhesion maturation. Focal adhesions 
have been shown to mature even in cells expressing motor-domain lacking myosin 
II (Legate et al., 2009) and while treatment with myosin II inhibitor or inhibitor of 
myosin phosphorylating Rho-associated protein kinase (ROCK) reduces number of 
mature focal adhesions, some mature adhesions are still observed (Pasapera et al., 
2010; Even-Ram et al., 2007; Humphries et al., 2007). These findings indicate that 
while actomyosin contractility induces focal adhesion maturation, it is not sufficient 
as such. It has been proposed that association with actin itself might be the 
elementary factor triggering maturation of adhesions (Oakes et al., 2012). 
Importantly, myosin II-mediated contractility and tension are essential for stress 
fibers, as myosin II inhibition leads to disassembly of stress fibers and thereby 
decreased association between focal adhesions and actin (Humphries et al., 2007; 
Smith et al., 2010). Interestingly, while fibrillar adhesions associate with actin, they 
persist even when myosin function is inhibited suggesting they are more dependent 
on the ECM topography than tension (Katz et al., 2000; Zamir et al., 1999; Biggs 
and Dalby, 2010). Taken together, these observations show that formation and 
maturation of adhesions and dynamics of the actin cytoskeleton are highly 
synergistic and different actin structures associate with distinct adhesion types. 
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2.3.2 Cell migration is essential for tissue development and 
maintenance 
Cell migration is an essential part of maintenance of healthy tissues, as it is crucial 
in many physiological processes, including embryonic development and 
organogenesis, immune system function and wound healing. However, dysregulated 
cell migration associates with different diseases, including inflammation and cancer 
(Shaw and Martin, 2016; De Pascalis and Etienne-Manneville, 2017).  
Cell migration can be triggered and modulated by various cues, such as growth 
factors and cytokines. In addition, the ECM is an imperative factor in cell migration, 
and the ECM composition, rigidity and topology are known to regulate cell migration 
speed and migration direction (Park et al., 2018; Doyle et al., 2012, 2015; Wolf et 
al., 2013). Interaction with the surrounding environment and coordinated attachment 
and de-attachment are a prerequisite for cell migration. Cells attach to the 
surrounding ECM and form adhesions that obtain varying strengths and last for 
varying times. The connected actin cytoskeleton generates force that is a prerequisite 
for the movement. Importantly, cells can also remodel the ECM to ease the 
migration. For example, cells exert the integrin-based adhesions and the actin 
cytoskeleton pushes and pulls the ECM (De Pascalis and Etienne-Manneville, 2017).  
Furthermore, cells can also express and secrete proteolytic enzymes, such as MMPs, 
that degrade the ECM to promote cell migration, and in case of cancer, invasion 
(Levental et al., 2009; Paszek et al., 2005; Linder, 2007; Friedl and Wolf, 2009). In 
addition to the secreted MMPs, a subgroup called membrane-type matrix 
metalloproteinases (MT-MMPs), such as MT1-MMP, remain tethered to the plasma 
membrane either through a transmembrane domain or by a 
glycosylphosphatidylinositol (GPI)-anchor (Itoh, 2015). MT-MMPs have been 
shown promote cancer cell migration, invasion and metastasis through digesting the 
ECM and by activating precursors of other secreted proteases (Itoh, 2015; Sato et 
al., 1994). For example cancer associated fibroblasts (CAFs) are known to remodel 
the surrounding ECM and thereby to promote cancer cell migration and proliferation 
(Labernadie et al., 2017; Glentis et al., 2017; Attieh et al., 2017).  
While cells can migrate both as single cells and collectively, in this thesis the 
focus will be on single cell migration. 
2.3.2.1 Cell adhesion and the actin cytoskeleton function synergistically 
in cell migration 
Cell migration includes polarization of cells so that they obtain a leading edge and a 
trailing edge. The leading edge and the trailing edge are characterised by distinct 
adhesive and cytoskeletal structures, and coordinated function of cell adhesion and 
re-organization of the actin cytoskeleton is a prerequisite for cell migration. (Charras 
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and Paluch, 2008; Ridley, 2011; Petrie and Yamada, 2012). The main example used 
in this thesis is lamellipodial cell migration, which occurs in four stages: adhesions 
hold a cell in place, actin polymerisation pushes the membrane forward extending 
protrusions, new adhesions are formed under the protrusions and the cell will 
gradually roll forward when the actomyosin structures contract and the trailing edge 
is released (Figure 7.) (Mattila and Lappalainen, 2008; Pollard and Borisy, 2003; 
Giannone et al., 2004). In addition, the process may be accompanied by proteolytic 
activity, which remodels the ECM and promotes migraton (Wolf et al., 2013; Friedl 
and Wolf, 2009). All in all, cell migration is a carefully regulated interplay between 
adhesion and actin dynamics. 
 
Figure 7.  Cell migration occurs in four stages: protrusion, adhesion, contraction and detachment. 
Image modified from (Mattila and Lappalainen, 2008). 
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Cell adhesion receptors, such as integrins, have an important role in signal 
transduction between a cell and its surroundings. In order to migrate, a cell needs to 
grab the ECM at the leading edge through integrin receptors and assemble adhesions, 
but at the same time, it needs to let go of the grip at the trailing edge (Pouwels et al., 
2013; Broussard et al., 2008; Huttenlocher et al., 1996; Doyle et al., 2015). This 
highlights the importance of adhesion assembly and disassembly regulation. 
Furthermore, integrin-based adhesions modulate directional cell migration by 
mediating signalling involved in chemotaxis (migration towards a soluble ligand), 
durotaxis (migration towards stiffer environment), and haptotaxis (migration 
towards higher ECM concentration) (Charras and Sahai, 2014; Conway and 
Jacquemet, 2019; Krause and Gautreau, 2014). 
In addition to adhesions, also different cytoskeletal structures have an important 
role in directing cell migration. For example, Arp2/3-mediated lamellipodia 
formation is essential for haptotaxis (King et al., 2016). However, it is non-essential 
for chemotactic cell migration (Wu et al., 2012). Furthermore, actin polymerisation 
at the leading edge is needed to extend the cell and form protrusions and cell-matrix 
adhesions (Zaidel-Bar et al., 2003; Krause and Gautreau, 2014; Caswell and Zech, 
2018; Wu et al., 2012). In addition, the actin cytoskeleton has an imperative role in 
force generation, which is essential for cell movement. In protrusive actin network, 
such as filopodia and lamellipodia, force is generated through actin polymerization 
and retraction, and the forces are generally modest compared to forces generated by 
actomyosin structures, such as stress fibers (Jacquemet et al., 2015; Le Clainche and 
Carlier, 2008). Lamellipodia are followed by lamella, in which nascent adhesions 
are coupled to transverse arcs promoting adhesion maturation and creating 
contractile actomyosin machinery needed for the trailing edge retraction (Burnette 
et al., 2011). Thereby, myosin II-containing actin stress fibers have an important role 
in pulling the cell forward and promoting detachment of the the trailing edge 
(Burnette et al., 2014; Vicente-Manzanares et al., 2009; Gardel et al., 2010; Burridge 
and Guilluy, 2016). Taken together, both dynamic regulation of cell adhesion and 
different actin structures are essential for cell migration and they act in an 
interdependent manner. 
2.3.2.2 Different migration modes 
In tissues, cells migrate within a 3D environment consisting of surrounding cells and 
the ECM. This requires a lot of plasticity – ability to adjust the cell shape and mode 
of migration. All migration modes discussed in this thesis share similar features, 
including polarization, protrusion, and contraction, but the cell shape and velocity 
during migration can vary a lot. For single cells migrating in 3D, there are many 
characterized modes of migration, including amoeboid (blebby), lamellipodial 
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(mesenchymal; described above for 2D) and lobopodial/pseudopodial migration 
(Figure 8.) (Krause and Gautreau, 2014; Charras and Paluch, 2008; Small et al., 
2002; Petrie et al., 2012; Sanz-Moreno and Marshall, 2010). While lamellipodial cell 
migration is the main example used in this thesis, also different migration modes will 
be introduced briefly. 
Lamellipodial migration is characterized by a leading edge that has a dense layer 
of branched actin filaments, a lamellipodium, followed by actin stress fibers that pull 
the trailing edge forward (Figure 8.). These actin structures associate with different 
kind of integrin-based adhesions, as described earlier in chapter 2.1.2. 
Lamellipodially migrating cells in 3D matrices are dependent on integrins and 
proteolytic activity (Wolf et al., 2003; Oudin et al., 2016). They can also employ 
other actin-rich, adhesive structures, such as filopodia and invadopodia. Importantly, 
while filopodia occur more typically in the proximity of the leading edge, 
invadopodia are commonly detected under the nucleus in 2D models, or ahead of the 
nucleus in 3D matrices (Wolf et al., 2007; Infante et al., 2018; Ferrari et al., 2019). 
Furthermore, while filopodia can push and pull the ECM, they lack proteolytic 
activity, which is pivotal for invadopodia (Linder et al., 2011; Jacquemet et al., 2015; 
Caswell and Zech, 2018; Shibue et al., 2013; Eddy et al., 2017). 
While cells employing lamellipodial migration are typically elongated, 
amoeboid migration is more typical to cells that are rounded. This is linked to the 
fact that amoeboid cell motility is integrin-independent and the protrusive structures 
involved in amoeboid cell migration are typically blebs of different sizes (Figure 8.). 
Importantly, while cells employing amoeboid migration have less obvious 
polarization compared to very elongated cells, polarization and a blebby leading 
edge is also needed to promote amoeboid migration (Charras and Paluch, 2008; 
Petrie and Yamada, 2012; Sanz-Moreno and Marshall, 2010). Blebbing is induced 
by increase in intracellular pressure and weakening of the actin cortex (Charras and 
Paluch, 2008; Sanz-Moreno and Marshall, 2010; Charras et al., 2005). Interestingly, 
lamellipodially migrating cells can be induced to switch to amoeboid migration by 
inhibiting integrins or proteolytic activity (Wolf et al., 2003). Consistently, 
amoeboid cell migration, does not depend on proteolytic activity (Wolf et al., 2003; 
Sahai and Marshall, 2003; Sabeh et al., 2009). 
Cells can also employ lobopodia to migrate. Lobopodia are blunt, cylindrical 
protrusions that are suggested to be a “hybrid version” between lamellipodial and 
amoeboid cell migration (Figure 8.). Lobopodia are actin-rich structures, but their 
formation is thought to be more dependent on hydrostatic pressure rather than actin 
polymerization, in contrast to lamellipodia, filopodia or invadopodia. Furthermore, 
lobopodially migrating cells are dependent on integrin-ECM adhesion (Petrie et al., 
2012, 2014; van Helvert et al., 2018).  
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Taken together, the leading edge morphology is imperative for the migration 
mode used. While different cell types may prefer using certain migration modes, one 
and the same cell can also utilize many different migration modes depending on the 
cellular context. The surrounding environment regulates the leading edge structures, 
and while lamellipodial migration may be the most common mode seen on rigid 2D 
surfaces, cells utilize various leading edge structures to migrate in 3D environments 
(Charras and Paluch, 2008; Petrie and Yamada, 2012, 2016; Friedl and Wolf, 2010). 
Migration in tight spaces requires protease activity, while more loosely organized 
ECM may favour amoeboid migration (Sabeh et al., 2009; Charras and Paluch, 2008; 
Wolf et al., 2003; Friedl and Wolf, 2009). Taken together, the migration mode and 
leading edge structures depend on the properties of the surrounding ECM, including 
the ECM composition, stiffness, elasticity and topography (Charras and Sahai, 2014; 
Doyle et al., 2012, 2015; van Helvert et al., 2018). 
 
Figure 8.  Cell have different leading edge structures depending on the migration mode. 
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2.4 The SHANK family of multidomain scaffold 
proteins 
The SH3 and multiple ankyrin repeat domains protein (SHANK) family consists of 
SHANK1, SHANK2 and SHANK3, and they were first identified from the 
postsynaptic density (PSD) of excitatory neurons where they act as scaffold proteins 
and mediate signalling (Lim et al., 1999; Naisbitt et al., 1999). SHANKs are large in 
size, and the full-length proteins consist of approximately 2000 amino acid residues. 
However, SHANKs have multiple splice variants, and thereby the detected sizes of 
proteins have been reported to range at least between 120-240 kDa (Lim et al., 1999; 
Naisbitt et al., 1999). SHANKs were first characterized to include five functional 
domains: ankyrin repeat region (ARR), Src homology 3 domain (SH3), PSD-
95/Discs large/ZO-1 domain (PDZ), polyproline region (PP) and sterile alpha motif 
(SAM) (Figure 9.). Later on, the very N-terminus of the protein, which was earlier 
considered to be a part of ARR, was recognized as an independent Shank/ProSAP 
N-terminal (SPN) domain (Mameza et al., 2013). SHANK1 and SHANK3 share a 
higher similarity, while SHANK2 most commonly appears to lack the N-terminal 
ARR part. While SHANK proteins were originally identified in the central nervous 
system (CNS) (Naisbitt et al., 1999), they are also observed in other tissues 
(Boeckers et al., 2002; Lim et al., 1999). Importantly, SHANK family proteins have 
different expression profiles. It was originally reported that in adult rat, SHANK1 is 
expressed exclusively in the brain, whereas SHANK2 is expressed in kidneys and 
liver in addition to the expression in brain, and SHANK3 is mainly expressed in 
heart, brain and spleen (Lim et al., 1999). Since that, SHANKs have also been 
observed to be expressed in most of the tissues in human body, while the expression 
levels remain the highest in the brain (Lilja et al., 2017). 
The major function of SHANK proteins is to interact with other proteins and 
thereby affect organization and signalling (Baron et al., 2006). As multidomain 
scaffold proteins, SHANKs can for example connect different types of glutamate 
receptor complexes to the actin cytoskeleton of dendritic spines. Furthermore, 
SHANK proteins can oligomerize through the C-terminal SAM-domain providing 
additional opportunities in scaffolding and organizing cellular structures and protein 
complexes (Baron et al., 2006; Lim et al., 1999; Naisbitt et al., 1999). However, 
while SHANKs have been studied extensively in the CNS, the knowledge of the role 
of SHANKs in other tissues remains scarce. Recently SHANK1 and SHANK3 were 
shown to have a function outside the CNS as they inhibit integrin function in cancer 
cells through sequestering active Rap1 and R-Ras (Lilja et al., 2017). This highlights 
the need of further studies of SHANK function outside the nervous system. In this 
thesis, the focus will be on SHANK3, which is most commonly spliced so that it 
includes the complete N-terminal part, and which is also expressed widely outside 
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the CNS (Lilja et al., 2017; Lim et al., 1999; Sheng and Kim, 2000; Naisbitt et al., 
1999). 
2.4.1 The N-terminal part of SHANK3 
Functions and significance of the SHANK3 N-terminal segment remained elusive 
for long, while C-terminal PDZ, PP and SAM domains were the main focus of 
research. The N-terminal part of SHANK3 consists of the SPN and ARR domains. 
Especially the knowledge of the SPN domain function has remained scarce. The 
ARR domain has several known interaction partners, including SHARPIN (Lim 
et al., 2001), α-fodrin (Böckers et al., 2001) (Figure 9.) and hyperpolarization-
activated cyclic nucleotide–gated (HCN) family ion channels (Yi et al., 2016). 
The SPN domain was first identified to interact with the ARR domain through 
intramolecular interactions and to restrict thereby interaction between ARR and 
other proteins (Mameza et al., 2013). However, recently SPN has also been shown 
to have functions that appear to be independent of ARR domain (Lilja et al., 
2017). 
The SPN domain is quite small, and is comprised of approximately 90 amino 
acids. Recently, the structure of SPN and ARR domains was resolved using X-ray 
crystallography, and the SPN domain was identified as a novel interaction site for 
active small GTPases Ras and Rap1. In addition, it was shown that SHANK1 and 
SHANK3 inhibit integrin function by sequestering R-Ras and Rap1 (Lilja et al., 
2017).  
 
Figure 9.  A schematic illustration of SHANK3 domains and actin-associated proteins that bind 
directly to SHANK3. 
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2.4.2 SHANK3 is an important actin regulator 
SHANK3 has been identified as an important actin regulator, as it modulates the 
synaptic actin cytoskeleton. So far there has been no reports of a direct interaction 
between SHANK3 and actin, but SHANK3 regulates the actin cytoskeleton through 
other ABPs and actin-related proteins, such as cortactin (Naisbitt et al., 1999), β-PIX 
(Park et al., 2003), actin-binding protein 1 (Abp1) (Haeckel et al., 2008), insulin 
receptor substrate of 53 kDa (IRSp53) (Bockmann et al., 2002), Ca²⁺/calmodulin 
(CaM)-dependent protein kinase IIα (CaMKKIIα) (Stephenson et al., 2017) and 
Abeldon interacting protein 1 (Abi-1) (Qualmann, 2004) (Figure 9.). Furthermore, 
other actin regulators, such as Cdc42 (Park et al., 2003), Rac1 and cofilin (Duffney 
et al., 2015), are downstream targets of SHANK3. Abnormal interactions between 
SHANK3 and its binding partners has been shown to lead to alterations in the 
synaptic actin cytoskeleton and dendritic spine morphology (Durand et al., 2012; 
Sarowar and Grabrucker, 2016). Not surprisingly, both knockdown and knockout of 
Shank3 reduce dendritic spine density and maturation (Grabrucker et al., 2011; J. et 
al., 2011; Wang et al., 2016, 2011; Bozdagi et al., 2010), whereas SHANK3 
overexpression promotes dendritic spine development (Zhou et al., 2016; Arons et 
al., 2012; Speed et al., 2015; Kouser et al., 2013; Verpelli et al., 2011; Jaramillo et 
al., 2016, 2017; Mei et al., 2016). Taken together, these studies demonstrate that 
SHANK3 has an important role in normal development of dendritic spines through 
regulation of the actin cytoskeleton. 
2.4.3 SHANK mutations associate with autism spectrum 
disorders and other neurological disorders 
Genes encoding all three SHANK family members have been identified as altered in 
autism spectrum disorders (ASD) (Berkel et al., 2010; Durand et al., 2007; Gauthier 
et al., 2009; Moessner et al., 2007). Furthermore, mutations and deletions of genes 
encoding SHANKs also result in autistic phenotype in mouse models (Duffney et 
al., 2015; Monteiro and Feng, 2017; Mei et al., 2016). 
As SHANKs are major scaffold proteins in the synapses, mutations altering 
SHANK function may associate with ASD through several different routes. 
Dysregulation and lack of SHANK3 has been linked especially to changes in 
dendritic spine morphogenesis and activity of synapses. Importantly, this has been 
reported to be caused, at least in part, by changed actin dynamics (Duffney et al., 
2015; Durand et al., 2012; Mei et al., 2016; Monteiro and Feng, 2017; Sarowar and 
Grabrucker, 2016). Consistently, SHANK-mediated changes in actin have been 
shown to alter many pivotal processes and signalling cascades in the dendritic spines 
(Sarowar and Grabrucker, 2016). Furthermore, stem cell derived neurons from 
autistic donors having Shank3 microdeletions have also abnormal actin cytoskeleton 
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(Kathuria et al., 2018). In line with these observations, the autistic phenotype caused 
by Shank3 depletion in mice can be rescued by inhibiting cofilin or activating Rac 
or its downstream effector p21-activated kinase (PAK) highlighting importance of 
SHANK3 as an actin regulator (Duffney et al., 2015). 
In addition to ASD, SHANK3 mutations associate also with other neurological 
and neurodevelopmental disorders. SHANK3 22q13 chromosome deletion leads to 
Phelan-McDermid syndrome, which is characterized by severe intellectual deficits 
(Bonaglia et al., 2006; Phelan and McDermid, 2012) and SHANK3 mutations that 
disrupt synapto-nuclear shuttling of SHANK3 are known to associate with 
schizophrenia (Grabrucker et al., 2014). Taken together, these observations highlight 
the importance of SHANK3 in normal development and function of synapses. 
2.4.3.1 Mutations in the N-terminal part of SHANK3 that are found in 
ASD-patients 
ASD-linked missense mutations have been recognized in all of the functional 
domains of SHANK3 and several mutations have been located in the N-terminal part 
of the protein (Boccuto et al., 2012; Durand et al., 2007; Gauthier et al., 2009). These 
N-terminal mutations include R12C, L68P, R300C and Q321R, but also other less-
studied mutations that have been found in patients with ASD, such as P141A, A198G 
and S341L (Table 1.) (Boccuto et al., 2012; Hassani Nia and Kreienkamp, 2018). 
The genetic relevance of SHANK3 mutations in ASD has been difficult to uncover, 
as some mutations, such as R300C, can be inherited from healthy parents. There is 
also indications that certain mutations may have different neurological effects 
depending on the environment and other factors. For example autism-linked 
mutation L68P was inherited from an epilectic father in the initial study that 
recognized the mutation (Gauthier et al., 2009). Altogether, the so far characterized 
mutations do not have a dominant effect on the disease. While most of the SHANK3 
mutations are very rare, R300C has a higher prevalence also in healthy individuals 
suggesting that it may rather be a gene polymorphism instead of being a pathogenic 
mutation (Hassani Nia and Kreienkamp, 2018). The ASD-associated mutations in 
the N-terminal SHANK3 and their molecular outcomes are summarized in Table 1. 
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Table 1.  Known ASD patient mutations within the N-terminal SHANK3. 
MUTATION LOCATION MOLECULAR OR CELLULAR 
OUTCOMES 
REFERENCE 
R12C SPN Reduced Ras- and Rap1-binding followed 
by reduced integrin inhibition, 
alterations in dendritic spines and their 
density, changes in actin 
(Durand et al., 2012, 
2007; Lilja et al., 2017) 
L68P SPN Interaction with Ras and Rap1 lost, unable 
to inhibit integrin function. Increased α-
fodrin and SHARPIN binding. 
Intramolecular interaction with SPN 
domain lost. 
(Gauthier et al., 2009; 
Lilja et al., 2017; 
Mameza et al., 2013) 
P141A ARR Not determined so far (Boccuto et al., 2012; 
Hassani Nia and 
Kreienkamp, 2018) 
A198G ARR Not determined so far (Durand et al., 2007) 
R300C ARR Alterations in dendritic spines and their 
density, changes in actin 
(Durand et al., 2012, 
2007) 
Q321R ARR Alterations in dendritic spines, actin 
accumulation in spines, altered neuronal 
growth cone motility 
(Durand et al., 2012) 
S341L ARR Not determined so far (Moessner et al., 2007) 
 
2.5 SHARPIN is a multifunctional adaptor protein 
SHARPIN (SHANK-Associated RH Domain Interactor) is a multifunctional adaptor 
protein that is approximately 45 kDa in size (Lim et al., 2001), and it consists of 
three functional domains: a pleckstrin homology (PH) domain (Stieglitz et al., 2012), 
a ubiquitin-like (UBL) domain and a Npl4 zinc finger (NZF) domain (Figure 10.) 
(Ikeda et al., 2011; Stieglitz et al., 2012). Interestingly, SHARPIN was originally 
identified as a SHANK interactor from the PSD of neurons (Lim et al., 2001). 
Indeed, the SHANK3 ARR domain binds to the SHARPIN UBL domain, but the 
function of this interaction remains obscure, and it may be that SHARPIN only 
interacts with certain SHANK splice variants (Lim et al., 2001; Mameza et al., 2013). 
Moreover, SHARPIN is ubiquitously expressed in most of the human and rodent 
tissues (Seymour et al., 2007) and in several human cancer cell lines (Rantala et al., 
2011). Since its original discovery, SHARPIN has been shown to bind many other 
proteins and to regulate their activity, including caspase-1 inactivation in sepsis 
(Nastase et al., 2016), phosphatase and tensin homolog (PTEN) inhibition (He et al., 
2010) and T cell antigen receptor (TCR) complex inactivation (Park et al., 2016). 
However, the most studied SHARPIN functions are its role in integrin activity 
regulation (Pouwels et al., 2013; Rantala et al., 2011; Gao et al., 2019; Kasirer-Friede 
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et al., 2019) and nuclear factor kappa B (NF-κB)-signalling pathways (Figure 10.) 
(Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011). 
Figure 10. A schematic illustration of SHANK3 domains and actin-associated proteins that bind 
directly to SHANK3. 
2.5.1 SHARPIN inhibits integrins and promotes NF-κB 
signalling as a part of LUBAC complex in a mutually 
exclusive manner 
SHARPIN binds to the cytoplasmic tails of α-integrins and it has been shown to 
reduce thereby recruitment of integrin activators, talin and kindlin, to the integrin 
β1-tail (Rantala et al., 2011). Importantly, SHARPIN binds to a highly conserved 
sequence within the α-tail, and thereby it is expected to inhibit all β1-subunit 
containing integrin heterodimers (Figure 10.) (Rantala et al., 2011). Furthermore, 
SHARPIN has been shown to inhibit β2-integrins in lymphocytes (Pouwels et al., 
2013) and αIIbβ3 integrins in platelets (Kasirer-Friede et al., 2019). Interestingly, a 
recent study also showed that SHARPIN may also bind to β1-integrin tails and form 
a complex with the β1-integrin and kindlin preventing talin recruitment and integrin 
activation (Gao et al., 2019). This brings up the question whether SHARPIN would 
be able to bind both integrin cytoplasmic tails at the same time through different 
domains, but this remains to be unravelled, as the binding site for integrin β1 has not 
been mapped in detail. Importantly, both SHARPIN and SHANK have been shown 
to inhibit integrins independently of each other (Lilja et al., 2017).  
The linear ubiquitin chain assembly complex (LUBAC) mediates the canonical 
NF-κB signalling pathway downstream of tumour necrosis factor α (TNFα), which 
is an important receptor upstream of inflammation, immune responses and cell death 
(Gerlach et al., 2011; Sasaki and Iwai, 2015). The LUBAC complex is an E3 ligase 
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that mediates NF-κB signalling by adding linear polyubiquitin chains to proteins, 
such as NEMO, which is an adaptor protein for IkB kinase (IKK) complex, an 
activator of NF-κB transcription factor. Importantly, aberrant NF-κB signalling 
associates with cancer and inflammatory disorders (Gerlach et al., 2011; Niu et al., 
2011; Sasaki and Iwai, 2015). The LUBAC complex consists of three proteins: 
SHARPIN, heme-oxidized IRP2 ubiquitin ligase 1 (HOIL-L1) and HOIL-1 
interacting protein (HOIP). HOIP acts as the catalytic subunit of the LUBAC 
complex, and while SHARPIN does not have its own enzymatic activity in the 
LUBAC complex, it has an important role as an adaptor protein. SHARPIN is needed 
to promote LUBAC function and NF-κB pathway signalling, and lack of SHARPIN 
has been observed to cause dysregulation of NF-κB signalling and cell death 
(Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011). Interestingly, while 
SHARPIN was originally reported to bind only HOIP, not HOIL-1L, a recent study 
shows that based on a X-Ray crystal structure of the complex, SHARPIN and HOIL-
1L could interact with newly identified LUBAC-tethering motifs (LTMs) (Figure 
10.) (Fujita et al., 2018). Taken together, SHARPIN and HOIL-L1 act as LUBAC 
complex adaptors and mediate stabilization of the complex, and all three complex 
members are needed for normal LUBAC function (Fujita et al., 2018; Gerlach et al., 
2011; Ikeda et al., 2011; Tokunaga et al., 2011). 
Importantly, the binding sites of α-integrins and HOIP have been mapped to 
overlap partially in the SHARPIN UBL domain. However, the interactions have been 
shown to be mutually exclusive. SHARPIN appears to be able to bind only either α-
integrin tail or HOIP at the time, but disruption of interaction between SHARPIN 
and α-integrins does not disrupt the HOIP binding site, and vice versa (De Franceschi 
et al., 2015). 
2.5.2 Spontaneus SHARPIN null mice develop psoriasis-like 
chronic proliferative dermatitis  
A spontaneous Sharpin null mutant mouse line has been identified (Seymour et al., 
2007). Importantly, these mice develop a chronic hyperproliferative dermatitis, and 
they are thereby referred to as cpdm mice. Furthermore, cpdm mice suffer from 
cutaneous and systemic eosinophilic inflammation, skin blistering and epidermal 
hyperproliferative thickening and defective, lymphoid organ development (Potter et 
al., 2014; Seymour et al., 2007). Importantly, lack of SHARPIN seems to impair 
LUBAC-mediated NF-κB activation, and cells isolated from cpdm mice are very 
sensitive for TNF-induced cell death (Gerlach et al., 2011; Ikeda et al., 2011). 
Importantly, simultaneous knockout of the Tnf gene can rescue the inflammatory 
phenotype of cpdm mice (Gerlach et al., 2011). Hoil-1L KO mice do not exhibit 
similar skin phenotype as cpdm mice and Hoil-1L KO mice and cells isolated from 
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them exhibit milder versions of similar phenotypes as cpdm mice, such as sensitivity 
to TNF-induced cell death (Ikeda et al., 2011; Tokunaga et al., 2009, 2011). 
Furthermore, simultaneous genetic ablation of both Sharpin and Hoil-1L has a 
strong, combinatory effect (Ikeda et al., 2011). Lack of HOIP, the catalytic subunit 
of the LUBAC complex, is embryonically lethal in mice (Fujita et al., 2018). 
Especially the epidermis, the outermost skin layer, is heavily affected in cpdm 
mice. Importantly, cpdm mice exhibit hyperkeratosis and high number of apopototic 
keratinocytes (Seymour et al., 2007). Furthermore, it has been shown that at least the 
TNF-dependent cell death induces skin inflammation in cpdm mice (Kumari et al., 
2014; Rickard et al., 2014). However, since SHARPIN is a multifunctional adaptor 
protein, also other SHARPIN interactors may contribute to the cpdm phenotype. For 
example, integrins have an important role in keratinocytes, that are the main cell type 
in the epidermis and other types of stratified, squamous epithelia (Watt, 2002).  
In normal, healthy epidermis, integrin expression is limited to the basal layer that 
connects the basal lamina to the epidermis (Hotchin et al., 1993, 1995; Watt, 2002), 
while in psoriasis-like conditions and hyperproliferative dermatitis, integrins are also 
expressed in suprabasal layers (Watt, 2002). Importantly, a transgenic mouse model 
overexpressing β1-integrins suffers from inflammatory, psoriasis-like skin phenotype, 
epidermal hyperplasia and abnormal keratinocyte differentiation (Carroll et al., 1995). 
Taken together, integrin β1-overexpressing mouse model exhibits very similar 
phenotype to SHARPIN null cpdm mice, which also have increased integrin activity 
in the epidermis (Rantala et al., 2011). However, the actual status and reasons behind 
integrin activation in cpdm mice remains to be unravelled, as inflammation may also 
trigger integrin activation. Importantly, dysregulated integrin activity has been shown 
to associate with skin blistering, inflammatory diseases and immune system 
malfunction (Bouvard et al., 2013; Watt, 2002) and integrin function blocking 
therapies have been shown to alleviate psoriasis-like phenotypes both in human (Ley 
et al., 2016) and mice (Conrad et al., 2007). Taken together, the cpdm mice phenotype 
shares many similarities with mouse models that have increased integrin activity, and 
the role of integrin activation in the cpdm phenotype awaits further investigation.  
2.5.3 The role of SHARPIN in cancer 
Interestingly, SHARPIN has been observed to be highly expressed in multiple 
different cancers, including human esophageal (Zhang et al., 2019), breast (De Melo 
and Tang, 2015; Zhuang et al., 2017), prostate (Zhang et al., 2014; Li et al., 2015), 
skin (Tamiya et al., 2018) and liver cancers (Table 2.) (Tanaka et al., 2016). 
Importantly, SHARPIN may promote cancer cell proliferation, survival and invasion 
through NF-κβ-signalling and its downstream mechanisms (Zhang et al., 2014; Li et 
al., 2015), and disruption of interaction between SHARPIN and other LUBAC 
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complex members have been shown to function as a potential target in LUBAC-
dependent cancers (Fujita et al., 2018; Yang et al., 2014). However, the mechanisms 
through which SHARPIN promotes cancer progression and tumorigenesis are 
various, and SHARPIN has also been shown to promote oncogenesis through other 
mechanisms than LUBAC- and NF-κB signalling (Table 2.). For example, 
SHARPIN has been shown to promote melanoma growth by enhancing activity of 
an epigenetic regulator protein, arginine methyltransferase 5 (PRMT5) (Tamiya et 
al., 2018). In addition, SHARPIN has been observed to promote estrogen-dependent 
cancer progression by stabilizing estrogen receptor α (Zhuang et al., 2017), and it is 
known to inhibit phosphatase and tensin homolog (PTEN) (He et al., 2010) and to 
promote degradation of p53, which are both tumour supressors (Yang et al., 2017).  
SHARPIN has also been shown to participate in ECM remodelling through 
upregulation of Versican, a chondroitin sulfate proteoglycan, and NF-κβ-mediated 
MMP expression (Tanaka et al., 2016).  
Interestingly, while SHARPIN is upregulated in many cancers and seems to 
promote oncogenesis, it has also been shown to inhibit cancer progression in 
esophageal cancer through inhibition of Hippo pathway signalling by poly-
ubiquitinylating yes-associated protein (YAP) and targeting it for proteosomal 
degradation (Zhang et al., 2019). Taken together, SHARPIN associates with multiple 
different human cancers, but there is no consensus what the mechanism would be 
how SHARPIN drives cancer progression. As SHARPIN is a multifunctional 
protein, it may promote oncogenesis through several different mechanisms and in a 
cancer type specific manner highlighting the need of further studies regarding the 
role of SHARPIN in cancer. 
Table 2.  How SHARPIN associates with different cancers. 
CANCER TYPE PROMOTES / INHIBITS 
CANCER 
PROGRESSION 
DOWNSTREAM TARGET 
/ MOLECULAR 
MECHANISM 
REFERENCE 
Breast Promotes Not defined / MDM2-
mediated induction of p53 
degradation / estrogen 
receptor α stabilization 
(De Melo and Tang, 
2015; Yang et al., 
2017; Zhuang et al., 
2017) 
Cervical Promotes Loss of PTEN (He et al., 2010) 
Esophageal Inhibits YAP inhibition (Zhang et al., 2019) 
Liver Promotes Upregulation of versican, 
NF-κβ-mediated MMP 
upregulation 
(Tanaka et al., 2016) 
Prostate Promotes NF-κβ-mediated effects (Li et al., 2015; Zhang 
et al., 2014) 
Skin/melanoma Promotes Induction of PRMT5 activity  (Tamiya et al., 2018) 
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3 Aims 
Integrins are the major cell surface adhesion receptors that mediate a plethora of 
cellular processes including cell proliferation, cell differentiation and signal 
transmission between a cell and its surrounding ECM. They are transmembrane 
proteins that mediate signalling bidirectionally, from the cell interior to regulate 
integrin-ECM interaction and in response to integrin-ECM adhesion to activate 
cellular signalling pathways, and connect the ECM to the actin cytoskeleton. 
Regulation of integrin activity has a pivotal role in several signalling pathways and 
not surprisingly, dysregulation of integrin function is implicated in a variety of 
disorders including cancer and inflammatory diseases (Bouvard et al., 2013; Hynes, 
2002). Importantly, our group has identified SHANKs (Lilja et al., 2017) and 
SHARPIN (Rantala et al., 2011) as novel integrin inhibitors. While both SHANK3 
and SHARPIN were originally identified from the CNS (Lim et al., 2001; Naisbitt 
et al., 1999), they have been shown since to be expressed also in many other tissues 
(Lilja et al., 2017; Rantala et al., 2011). As the integrin-based cell adhesion and the 
actin cytoskeleton are highly interdependent, I wanted to characterise how SHANK3 
and SHARPIN affect cytoskeletal structures, such as filopodia and lamellipodia. In 
addition, since integrins are critical regulators of the homeostasis of the epidermis, I 
wanted to investigate the role of integrin activity in the hyperproliferative dermatitis 
characteristic to SHARPIN-deficient cpdm mice (Seymour et al., 2007). Although 
increased integrin activity is observed in the epidermal layer of cpdm skin (Rantala 
et al., 2011), it has remained enigmatic whether it is secondary to the systemic 
inflammation in mice.  
 
The specific aims of my thesis are: 
I. Characterization of the role of SHANK3 SPN domain in filopodia 
formation 
II. Identification of novel SHARPIN interactors and characterization of its 
role in lamellipodia formation 
III. Investigation of how increased integrin activity caused by lack of 
SHARPIN modulates the hyperproliferative dermatitis phenotype in 
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4 Materials and Methods 
This chapter describes the methods and experimental procedures in which I have 
been personally involved with. Precise details, such as catalogue numbers, and 
microscope objective and camera information, can be found in original articles. 
Roman numerals (I, II and III) indicate in which original articles each method was 
used. 
4.1 Cell lines (I, II) 
Multiple different cancer and non-cancer cell lines were used in the original 
articles, including CHO (chinese hamster ovary), HEK-293 (hamster embryonic 
kidney), HeLa (human cervical cancer), MEF (mouse embryonic fibroblast), NCI-
H460 (human non-small lung adenocarcinoma) and U2OS (human osteosarcoma) 
cells (Table 3.). All cell culture reagents were obtained from Sigma or GIBCO. 
All cell lines were obtained either from American Type Culture Collection 
(ATCC) or Leibniz Institute DSMZ-German Collection of Microorganisms and 
Cell Cultures (DSMZ). Cells were regularly tested negative for mycoplasma 
infection. All cell lines were grown in a humified incubator at 37 ⁰C supplemented 
with 5 % CO2. 
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Table 3.  Cell lines used in the original articles. DMEM = Dulbecco’s Modified Eagle’s Medium, 
FBS = fetal bovine serum, MEM = minimum essential medium, pen-strep = penicillin-
streptomyocin. 
CELL LINE CULTURE MEDIUM ORIGINAL ARTICLE 
CHO α-MEM base, 5 % FBS, 2 mM L-glutamine, 1 % 
pen-strep 
I 
HEK-293 DMEM base, 10 % FBS, 2 mM L-glutamine, 1 % 
pen-strep 
I, II 
HeLa DMEM base, 10 % FBS, 2 mM L-glutamine, 1 % 
sodium pyruvate, 1 % non-essential amino acids, 
2 % HEPES, 1 % pen-strep 
II 
MEF (CPDM & WT) DMEM base, 10 % FBS, 1 % sodium pyruvate 
1 % non-essential amino acids, 1 % pen-strep, 
0.001% β-mercapto-ethanol 
II 
NCI-H460 RPMI1640 base, 10 % FBS, 2 mM L-glutamine, 1 
% non-essential amino acids, 1% sodium pyruvate 
and 1% glucose, 1 % pen-strep 
II 
U2OS DMEM base, 10 % FBS, 2 mM L-glutamine, 1 % 
pen-strep 
I, II 
 
4.1.1 Generation of SHARPIN-knockout cell lines using 
CRISPR (II) 
Sharpin knockout NCI-H460 cell lines were created using CRISPR genome 
engineering technique. GuideRNAs were designed with MIT CRISPR Designer 
(http://crispr.mit.edu/), and two guideRNAs (5’-TGGCTGTGCACGCCGCGGTG-
3’, 5’-TCAGTTTCCTACACCATCCG-3’) were obtained from Sigma. GuideRNAs 
were cloned into pSpCas9(BB)-2A-GFP (PX458) described earlier in (Ran et al., 
2013). Both guideRNA plasmids were transfected into cells. GFP expressing cells 
were sorted into single cell cultures with FACSaria IIu Cell Sorter (BD Biosciences). 
Single cell cultures were grown and screened using PCR. For DNA samples, cells 
were trypsinized, spun down, resuspended in distilled water and boiled for 10 min. 
Forward primer used was 5’-GTGTCCATTTGTGGGCAAAG and reverse primer 
5’-GGCACTGACCATTCTGTCCT. PCR was done with Kod XtremeTM Hot Start 
DNA Polymerase (EMD Millipore, #71975). Length of the PCR product was 
approximately 900 bp, but in the case of cleavage with both guideRNA plasmids the 
product was approximately 500 bp shorter due to cleavage of sequence between 
them. We selected two knockout cell lines, that were cleaved with two guideRNA 
plasmids based on PCR, and did not produce SHARPIN protein measured with 
western blot. Control cell line was one of the flow cytometry-sorted single cell 
cultures that still produced long PCR product and expressed normal amount of 
SHARPIN based on western blot detection. 
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4.2 Transient transfections, plasmids and siRNAs 
(I, II) 
Lipofectamine 3000 and P3000 Enhancer reagent (Thermo Fisher Scientific) were 
used to transiently transfect plasmids into cells, and Hiperfect (Qiagen) and 
RNAiMAX (Thermo Fisher Scientific) were used to introduce RNAi 
oligonucleotides into cells for silencing gene expression. The plasmids used in this 
thesis are listed in Table 4. Point mutations were introduced to original wild type 
(WT) plasmids using QuickChange II mutagenesis kit (Agilent) or ordered from 
Gene Universal Inc. siRNAs targeting human SHARPIN and a scramble control 
were obtained from Qiagen, and siRNAs against Arp3 and HOIP were obtained from 
Dharmacon. 
Table 4.  Plasmids used in the original articles. FL = full-length protein, GFP = green fluorescent 
protein, GST = glutathione S-transferase, RFP = red fluorescent protein, WT = wild type. 
PLASMID ORIGINAL ARTICLE 
eGFP-C1  I, II 
GFP-Arp2 II 
GFP-Cofilin-1 I 
GFP-Rap1 Q63E I 
GFP SHANK3 SPN WT & point mutants R12C and Q37A/R38A I 
GFP SHANK3 FL WT & point mutants R12C, Q37A/R38A and N52R I 
GFP SHARPIN WT & point mutant V240A/L242A II 
GFP-Talin I 
GST SHANK3 SPN WT and Q37A/R38A I 
GST SHANK3 SPN-ARR WT and N52R I 
Kindlin-2-GFP I 
mCherry-SHARPIN II 
mEmerald-Lifeact II 
mRFP-N1 I, II 
mRuby-Lifeact I 
Myo10-mCherry I 
pspCas9(bb)-2a-GFP (px458), (Ran et al. 2013) II 
SHANK3-mRFP FL and fragments of different lengths I 
SHANK3 SPN-ARR-mRFP, WT and N52R I 
SUMO SHANK3 SPN WT I 
SUMO SHANK3 SPN-ARR WT I 
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4.3 Mice (III) 
The spontaneous SHARPIN null cpdm mouse strain (Seymour et al., 2007), 
C57BL/KaLawRij-Sharpincpdm/RijSunJ mouse strain, hereafter referred to as 
Sharpincpdm/cpdm, cpdm/+ or +/+), was obtained from The Jackson Laboratory (#007599, 
Bar Harbor, ME, USA). Tnfr1-Sharpin double knockout Tnfrsf1atm1Imx 
Sharpincpdm/cdpm mice, Tnfrsf1atm1Imx Stock No: 003242; hereafter referred to as Tnfr1-
/-), was obtained from Prof. H. Walczak (University College London, UK). DNA 
samples were extracted from skin pieces gotten from ear marking using KAPA 
Mouse Genotyping Kit (KK7302). TaqMan SNP Genotyping Assay Mix (5793982, 
Applied Biosystems) and TaqMan Universal PCR Master Mix were used to detect 
the Sharpincpdm mutation. The Tnfr1 phenotype was determined based on PCR 
amplification. Both Sharpincpdm/? and Sharpincpdm/?-Tnfr1+/? colonies were maintained 
through breeding of heterozygous mice. Single and/or double knockout mice and 
their WT or heterozygous littermate controls were selected to experiments based on 
genotyping results. 
4.3.1 Isolation of primary keratinocytes from mouse 
epidermis (III) 
6-8-week old Tnfr1-/--Sharpincpdm/cpdm and WT or heterozygous litter mate controls 
were sacrificed, dorsal skin was shaved with a scalpel and a skin piece was 
harvested in cold PBS (phosphate buffered saline) supplemented with penicillin 
and streptomycin. The piece of skin was incubated overnight in 0.25 % porcine 
trypsin (Sigma) in Ca2+-free Hank’s Balanced Salt Solution (HBSS) at +4 ⁰C on a 
shaker (~90 rpm). Next day, dermis was removed from the epidermis using 
forceps. The remaining epidermis was minced mechanically into finer pieces and 
incubated in 0.2 % Collagenase XI (Sigma) in HBSS at 37 ⁰C for 30 min. During 
the incubation, the mixture was resuspended and stirred every 5-10 min to promote 
dissociation of keratinocytes from tissue. The suspension was filtered through a 
cell strainer (70 μm; BD Biosciences) to separate keratinocytes from remaining 
tissue material. The separated keratinocytes were places on ice and incubated with 
20 U/ml DNase I (Roche) in HBSS for 5 min, after which DNAase was removed 
by centrifugation and cells were further treated according to downstream assays in 
question. The cells were grown in a humified incubator at 32 ⁰C supplemented with 
CO2. 
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4.3.2 Proliferation assay of keratinocytes and treatment with 
β1-integrin blocking antibody (III) 
After isolation, equal amounts of mouse primary keratinocytes were plated on 96-
well plate coated with 20 µg/ml Collagen Type I. Cells were grown in FAD medium 
(3.5:1.1 DMEM and Ham’s F12 Nutrient Mixture) containing 10 % chelated FBS, 
100 μg/ml penicillin-streptomycin, 5 μg/ml insulin, 100 pM choleratoxin, 10 ng/ml 
epidermal growth factor (EGF), 100 U/ml sodium pyruvate, and 0.5 μg/ml 
hydrocortisone. On the first day after the plating, the media was replaced with fresh 
media containing either with 10 µg/ml anti-Itgb1 (anti-mouse CD29 Armenian 
hamster IgG, Biolegend) or isotype IgG control antibody (Biolegend). The treatment 
media was replaced with fresh media every other day. The effect of treatment on 
keratinocyte proliferation was quantified using Cell Proliferation Reagent WST-1 
tetrazolium salt (Roche) according to manufacturer’s instructions. Detection was 
performed by analysing absorbance at 450 nm with BioTek Synergy H1 Hybrid 
Multi-Mode Microplate Reader. Samples were subjected to WST-1 assay as 
duplicates and the relative proliferation was calculated by normalizing proliferation 
to amount of cell at different time points to day zero. 
4.4 Antibodies and fluorescent dyes 
Antibody-based detection was used in flow cytometry, immunofluorescence 
microscopy and western blot. Staining protocols are described together with the 
aforementioned methods. Primary antibodies and their associated details are listed 
in table 5. The secondary antibodies AlexaFluor 488-, 555-, 568, and -647 IgG 
against mouse and rabbit were used in flow cytometry, immunofluorescence and 
immunohistochemistry microscopy, and obtained from Invitrogen, Life 
Technologies. Secondary antibodies IRDye680 and IRDye800 against mouse and 
rabbit used in western blot were obtained from (LI-COR). Details of directly 
fluorochrome-conjugated actin dyes can be found from Table 6. DAPI (4',6-
diamidino-2-phenylindole, dihydrochloride) was used to visualize nuclei in 
microscopy.  
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Table 5.  Primary antibodies used in the original articles. FACS = flow cytometry, IF = 
immunofluorescence, WB = western blot. 
ANTIGEN MANUFACTURER PRODUCT 
CODE 
APPLICATION DILUTION ORIGINAL 
ARTICLE 
Active 
integrin β1 
(clone 
9EGeg7) 
PD Pharmingen 553715 FACS / IF 1:50 / 1:100 III 
Arp2 Abcam ab47654 IF / WB 1:100 / 
1:1000 
II 
β-actin Sigma A1978 WB 1:1000 I 
CD29-647 
(total integrin 
β1) 
BioLegend 102210 FACS 1:50 III 
CD31-Pacific 
Blue 
(PECAM-1) 
BioLegend 102422 FACS 1:50 III 
CD45-Pacific 
Blue 
(PTPRC) 
BioLegend 103125 FACS 1:200 III 
CD49f-488 
(integrin α6) 
BioLegend 313608 FACS 1:20 III 
Cortactin Merck Millipore 05-180 IF / WB 1:100 / 
1:1000 
II 
GAPDH HyTest 5G4MaB6C5 WB 1:10000 II, III 
GFP Abcam ab1218 + 
ab69507 
IF / WB 1:100 / 
1:1000 
I, II 
GST CST 91G1 WB 1:1000-5000 I, II 
Integrin α6 Serotec NKI-GoH3 IF 1:200 III 
Keratin 14 Biosite PRB-155P IF / WB 1:600 / 
1:1000 
III 
Non-muscle 
myosin IIA 
BioLegend 90980 IF 1:1000 I 
PB1 (integrin 
α5) 
Developmental 
studies hybridoma 
bank 
- FACS 1:7,5 I 
Phospho 
myosin light 
chain 
CST 3674 IF 1:100 I 
SHARPIN Abcam ab69507 IF 1:100 II 
Sharpin Proteintech 14626-1-AP WB 1:1000 II, III 
Vimentin CST D21H3 WB 1:1000 III 
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Table 6.  Directly conjugated actin dyes used in the original articles. 
DYE MANUFACTURER PRODUCT 
CODE 
DILUTION ORIGINAL 
ARTICLE 
Atto-phalloidin-647 Sigma 65906 1:500 I, II 
Atto-phalloidin-740 Sigma 07373 1:75 I 
Phalloidin Alexa Fluor 488 Invitrogen A12379 1:200 I 
Phalloidin Alexa Fluor 647 Invitrogen A22287 1:200 I 
Sir-actin-647 Spirochrome SC001 1:5000 I 
 
4.5 Other reagents, drugs and inhibitors (I, II, III) 
Fibronectin from bovine plasma and collagen type I from rat tail were obtained from 
Merck-Millipore and used to coat cell culture plates and glass-bottom dishes. The 
Arp2/3 complex inhibitor CK666 was obtained from Sigma.  
4.6 Flow cytometry (fluorescence-activated cell 
sorting, FACS) (I, III) 
To analyse integrin activity in primary mouse keratinocytes, cells were isolated as 
described above, kept on ice and fixed with 2 % paraformaldehyde (PFA) in PBS for 
10 min at RT. PFA was removed by centrifugation, followed by suspending the cells 
in cold Tyrodes buffer (10 mM Hepes-NaOH pH 7.5, 137 mM NaCl, 2.68 mM KCl, 
0.42 mM NaH2PO4, 1.7 mM MgCl2, 11.9 mM NaHCO3, 5 mM glucose and 0.1 % 
bovine serum albumin (BSA)). The cells were stained with directly fluorochrome-
conjugated primary antibodies (described in Table 5) diluted in Tyrodes. After the 
antibody incubations, cells were washed with Tyrodes and finally resuspended in 
PBS before the analysis.  
To analyse the role of SHANK3 SPN mutants in integrin activity, GFP-tagged 
SPN constructs were expressed in CHO cells. The cells were detached gently using 
Hyclone® HyqTase (Thermo Fisher Scientific). The cells were pre-incubated with 
5 mM EDTA (integrin-inhibiting negative control) or PBS, after which they were 
incubated with Alexa Fluor 647-labelled fibronectin 7-10 fragment. After the 
incubation, cells were washed with cold Tyrodes buffer and fixed with 2 % PFA in 
PBS. The cells were stained for total α5β1-integrin for 40 min followed by 
incubation with Alexa Fluor-conjugated secondary antibody. Samples were washed 
with cold Tyrodes and resuspended in PBS before analysis. 
All FACS samples were analysed using BD Biosciences LSRFortessa and 
FlowJo and Flowing Software analysis softwares. 
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The integrin activity index was calculated with the following equation: 
 
Integrin activity index = (F-F0) / (Fintegrin) 
• F = geometric mean fluorescence intensity of fibronectin fragment 
binding 
• F0 = is the mean fluorescent intensity of fibronectin fragment binding in 
negative control sample  
• Fintegrin = the normalized average mean fluorescent intensity of total αβ1 
integrin (PB1)  
4.7 Protein expression and purification (I) 
Recombinant proteins were expressed in competent E. coli BL21 strain and grown 
in Luria-Bertani (LB) broth supplemented with selection antibiotics. The production 
of transformed proteins was induced by addition of isopropyl β-D-1-
thiogalactopyranoside (IPTG), and the proteins were purified from the prepared 
bacterial lysate with either glutathione sepharose (GE Healthcare) or Protino Ni-Ted 
resin (Macherey-Nagel) depending on if the protein in question has a glutathione S-
transferase (GST) or a polyhistidine tag. Proteins were eluted from beads with 
reduced L-glutathione or imidazole, respectively. Dialysis of proteins and buffer 
exchange was performed overnight at +4C using Thermo Scientific Slide-A-Lyzer™ 
Dialysis Cassettes. The exact details of buffer recipes can be found from the original 
articles I. 
4.8 SDS-PAGE gel electrophoresis, Coomassie 
Blue staining and western blotting (I, II, III) 
SDS-PAGE gel electrophoresis was used to separate purified proteins and protein 
extracts based on size under denaturing conditions. Coomassie Blue staining was 
used to analyze different steps of protein production and purification. After run, the 
gel was washed briefly with tap water and incubated in Expedeon Instant Blue 
Coomassie Protein Stain overnight at RT. After incubation, the gel wash washed 
with plenty of tap water. For western blot detection, SDS-PAGE gel was transferred 
to Trans-Blot® Turbo™ nitrocellulose membranes using with Bio-Rad Trans-Blot® 
Turbo™ Transfer System. Membranes were blocked for 1 h at RT either with 5 % 
milk in TBST or with Thermo Scientific Pierce™ StartingBlock™ Blocking Buffers 
diluted in PBS according to manufacturer’s protocol. Primary antibodies and 
secondary antibodies were diluted in the blocking buffer. Primary antibodies were 
incubated overnight at +4C, and secondary antibodies were incubated for 1 h at RT. 
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Blocking and incubations were done under constant rotation or shaking. Antibodies 
used and their dilutions are listed in Table 5. Both Coomassie gels and western blot 
membranes were scanned with either Odyssey infrared scanner (LI-COR) or Bio-
Rad Chemidoc. 
4.9 Microscopy sample preparation 
Different microscopy techniques were used to image cells and tissue samples in all 
original articles included in this thesis. For the sample preparation, cells were plated 
on either on glass coverslips, glass-bottom dishes (MatTek and Cellvis) or 8-well µ-
slides (Ibidi) for times indicated in the original articles. For given experiments the 
cell culture plates and glass surfaces were coated with fibronectin or collagen. 
Samples were imaged either as fixed with 4 % PFA or live. After fixing, samples 
were stained either blocked with 10 % horse serum in PBS or quenched with 1 M 
glycine in PBS. Antibodies and actin dyes were either diluted directly to PBS or in 
10 % horse serum in PBS. Both primary (Table 5) and secondary antibodies or actin 
dyes (Table 6.) were incubated for 30 min at RT or overnight at + 4C. Glass 
coverslips were mounted on glass slides using Mowiol mounting media, and glass-
bottom dishes were imaged as filled with PBS. For live-imaging, cells were kept in 
their normal culture medium supplemented with 10 mM HEPES. 
Mouse skin samples were prepared from O.C.T TissueTek (Sakura)-embedded 
frozen tissue sections plated on glass slides and ringed with PapPen. The sections 
were fixed with 4 % PFA and blocked and permeabilised with 2 % BSA and 0.1 % 
Triton-X in PBS. Primary (Table 5.) and secondary antibodies were diluted in 2 % 
BSA in PBS at RT for 1 h. After the secondary antibody, samples were washed 3 
times with PBS, and one time with distilled water. The washed samples were 
mounted with Vectashield mounting medium. 
4.9.1 Micropatterns 
For some experiments, cells were confined to certain shapes, such as crossbow 
shape) using micropatterns. Micropatterns were created on glass coverslips as 
described earlier (Azioune et al., 2009). The created patterns were coated with 50 
μg/ml fibronectin. Furthermore, 555-labelled BSA and Alexa Fluor 488- or 647-
labelled fibrinogen were used to visualize the patterns. Cells were plated on 
patterns for 3-4 hours, after which they were fixed, stained and imaged as described 
above. 
Siiri Salomaa 
 60
4.10 Microscopes and image analysis 
Different confocal microscopes (3i Marianas Spinning disk confocal microscope, 
Carl Zeiss LSM780 laser scanning confocal microscope and Carl Zeiss LSM880 
laser scanning confocal microscope LSM880 with AiryScan module) were used to 
image selected focal plains and to get high-resolution image data of cellular 
structures throughout the cell or tissue samples. Furthermore, they were used for 
fluorescence recovery after photobleaching (FRAP) experiments. Total internal 
reflection fluorescence microscopy (TIRF) microscope (Carl Zeiss Laser-TIRF 3 
Imaging System) was used for imaging bottom plane structures, such as adhesions 
and actin, from both fixed and live samples. Widefield microscopes (Zeiss AxioVert 
200 M and Nikon Eclipse Ti2-E) were used to image overall cell morphology and 
localization of different proteins in cells, as well as live cell migration experiments. 
Detailed information about the cameras and objectives the microscopes were 
supplemented with can be found from the original articles I, II and III. 
Most of the image analysis was performed with ImageJ and its different plug-
ins, including, Chemotaxis, coloc 2 and MTrackJ. Live-cell videos were prepared 
with ImageJ. FRAP data was analysed using SlideBook 6 software and Carl Zeiss 
Zen Black FRAP analysis modules. FilamentSensor software (Eltzner et al., 2015) 
was used to quantify thick actin bundles. 
4.10.1 Wound healing assay 
Equal amounts of cells were seeded to Essen BioScience IncuCyte™ ImageLock™ 
96-well plate. The day after splitting when cells had formed a confluent monolayer, 
a scratch wound was made using Essen BioScience WoundMaker™. After making 
the wound, wells were washed to remove detached cells and fresh media was added. 
Imaging was started directly after making the wound using Essen BioScience 
IncuCyte™ and images were taken by IncuCyte Zoom™ System (Essen BioScience) 
every two hours until the wound was closed. The wound closure was analyzed with 
the IncuCyte Zoom software. 
4.11 Statistical analysis 
GraphPad Prism 7 software was used for all statistical analyses. Comparison 
between two groups was done Student’s t-test with Welch’s correction or Mann-
Whitney T-test depending if the data was normally distributed. One sample t-tests 
were further subjected to Bonferroni sequential correction. Kruskal-Wallis non-
parametric test with Dunn’s multiple comparison test was used when comparing 
several sample groups. 
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5 Results and discussion 
5.1 SHANK3 inhibits filopodia formation by 
sequestering active Rap1 through its N-
terminal SPN domain and modulating integrin 
activation (I) 
At the time when this study was initiated, very little was known about the function 
of SHANK3 outside the CNS. Importantly, our group had recently identified a novel 
function for SHANK1 and SHANK3 as inhibitors of integrins using X-ray protein 
crystallography. The structure revealed that the N-terminal SPN-domain of 
SHANK3 adopted a Ras-association domain (RA) like fold, suggesting that it could 
function as a novel interaction site for Rap1- and Ras-family small GTPases. 
Furthermore, our group showed that the SPN domain has a high affinity for active, 
guanosine triphosphate (GTP)-bound forms of Rap1 and Ras-family proteins, but it 
does not bind inactive, guanosine diphosphate (GDP)-bound variants (Lilja et al., 
2017). In conclusion, SHANKs inhibit integrin function by sequestering the integrin 
activating GTP-bound Rap1 and R-Ras through its SPN-domain limiting their 
bioavailability at the plasma membrane. Interestingly, autism-linked SHANK3 
patient mutations, R12C and L68P (Durand et al., 2007; Gauthier et al., 2010), are 
within the SHANK3 SPN domain, and we found that these mutations have also 
reduced ability to inhibit integrin activation (Lilja et al., 2017). 
Migrating cells use filopodia to probe the environment, and maturation of 
filopodia tip adhesions to focal adhesions directs cell migration (Jacquemet et al., 
2016, 2019). Importantly, filopodia formation requires Rap1/talin-mediated integrin 
activation axis (Jacquemet et al., 2016; Lagarrigue et al., 2015), but the role of 
integrin inactivators in filopodia regulation remains poorly defined. As we recently 
recognized SHANK1 and SHANK3 as integrin inhibitors and showed that they 
inhibit cancer cell migration, we wanted to characterise their role in filopodia 
formation. We focused on SHANK3, as it is widely expressed also outside the CNS 
(Lilja et al., 2017). Filopodia are dynamic structures, and their formation can be 
induced by multiple proteins. Here, we used expression of myosin 10 (Myo10) to 
promote filopodia formation in U2OS human osteosarcoma cells. U2OS cells have 
a low Myo10 expression as such, and they are thereby a good model for filopodia 
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induction (Young et al., 2018). In line with our hypothesis, cells co-expressing 
fluorescently tagged Myo10-mCherry and GFP SHANK3 had significantly lower 
number of Myo10-positive filopodia compared to cells co-expressing Myo10-
mCherry and GFP control (I, Fig. 1B-C). Since we showed in our previous 
publication that the N-terminal SHANK3 SPN domain was responsible for integrin 
inhibition, we hypothesized that expression of the SPN domain alone would be 
sufficient to inhibit filopodia formation. Consistently, co-expression of GFP SPN 
and Myo10-mCherry reduced number of Myo10-positive filopodia significantly (I, 
Fig. 1D-E), but we were surprised to see that GFP SPN also overlapped with 
filamentous structures throughout the cell (I, Fig. 1D). 
5.1.1 The SHANK3 SPN domain colocalises with actin and 
binds it directly 
SHANK3 has been shown to interact with and to modulate function of many actin 
regulators (Figure 9., I, Fig. 2A), but there has been no reports of a direct interaction 
between SHANK3 and actin so far. Furthermore, to date the only identified binding 
partners of the very N-terminal SHANK3 SPN domain are limited to Ras family 
proteins and Rap1 (Lilja et al., 2017), and the knowledge of the SPN domain function 
remains scarce. We found, using immunofluorescence confocal microscopy, that 
GFP SPN colocalised with F-actin staining (I, Fig. 1D, F-G). Furthermore, in a GFP 
co-immunoprecipitation assay, GFP SPN pulled down β-actin from cell lysate 
indicating that the SPN domain associates with actin (I, Fig. 3F). However, 
colocalisation and co-immunoprecipitation assays can also detect indirect 
association as protein complexes. Therefore, to determine if the SPN domain 
interacts directly with actin, we employed actin co-sedimentation assay with 
recombinant SPN protein and purified F-actin. The actin co-sedimentation assay is 
based on centrifugation with speeds at which F-actin will form a pellet. Proteins that 
bind F-actin should thereby also be present in the pellet fraction after the 
centrifugation. We observed that recombinant SPN protein co-sedimented with F-
actin and was present in the pellet, but when it was centrifuged without actin 
(negative control) it remained in the supernatant fraction confirming that SPN only 
localised to the pellet fraction when bound to F-actin (I, Fig. 2C-D, S2C). Taken 
together, these data indicate that the SPN domain binds actin directly. 
5.1.2 Creation and validation of an actin-binding deficient 
SPN mutant 
The X-ray crystal structure from our previous publication revealed that the SHANK3 
SPN domain has a high similarity to F0 motif of talin four-point-one, ezrin, radixin, 
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moesin (FERM) domain (I, Fig. S3A) (Goult et al., 2010; Lilja et al., 2017). Talin 
F0 is similar to kindlin F0 domain (I, Fig. S3B) (Goult et al., 2010), and interestingly, 
kindlin-2 F0 domain has been reported to bind actin directly (Bledzka et al., 2016). 
Bledzka et al. mapped potential kindlin-2 F0 actin-binding sites, to surface residues 
L47 and K48 based on sequence similarity to other known ABPs, and showed that 
mutation of these residues into alanines substantially reduced actin binding (Bledzka 
et al., 2016). This inspired us to compare the SPN domain with kindlin-2 F0 domain 
to identify potential actin-binding residues. Sequence alignment and structure 
superimposition of the kindlin-2 F0 and the SHANK3 SPN domains indicated that 
Q37 and R38 would be the corresponding amino acids in the SPN domain (I, Fig. 
3A-B, S3C). We introduced the Q37A/R38A point mutations into GFP SPN and 
GST SPN expression vectors, and studied how these point mutations affected 
interaction between the SPN domain and actin. In a GFP co-immunoprecipitation 
assay, GFP SPN Q37A/R38A pulled down less β-actin compared to GFP SPN WT 
(I, Fig. 3F). In line with this, GST SPN Q37A/R38A co-sedimented approximately 
40 % less with F-actin compared to WT (I, Fig. 3G-H). Taken together, these data 
indicate that Q37A/R38A point mutation interferes with the SPN-actin-binding site 
such that the actin-binding is significantly reduced. However, it is likely that the full 
actin-binding site of the SHANK3 SPN domain involves also other amino acid 
residues, as the actin binding is not completely abolished. Nevertheless, the 
Q37A/R38A point mutant provides a valuable tool for studying effects of reduced 
interaction between the SHANK3 SPN domain and actin. 
Consistent with the reduced actin binding, GFP SPN Q37A/R38A did not 
colocalise with actin when expressed in cells (I, Fig. 3C-E). As the SHANK3 SPN 
domain also sequesters active, integrin-activating Rap1, we wanted to investigate if 
previously characterized Rap1-binding deficient mutant R12C (Lilja et al., 2017) 
would have altered colocalisation with actin. However, we observed that GFP SPN 
R12C expressing cells had very similar phenotype with GFP SPN WT, and they both 
colocalised strongly with F-actin (I, Fig. 3C-E). These findings indicate that 
interaction between SPN and actin does not depend on interaction with active Rap1 
and integrin inhibitory function. 
5.1.3 The SPN domain binds actin directly, but it does not 
bundle actin filaments together 
As we observed a strong colocalisation between GFP SPN WT and thick actin 
filaments (I, Fig. 3C-E), we speculated whether the SPN domain could bundle actin 
filaments together and promote thereby stress fiber formation. We performed a low-
speed actin co-sedimentation assay in which actin only goes to pellet in bundled 
form. Our results show that while recombinant SPN protein and actin are present in 
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pellet after high-speed centrifugation (I, Fig. 2C), they both remain in the supernatant 
after a low-speed centrifugation (I, Fig. 2D). These results indicate that while SPN 
domain binds F-actin, it does not bundle actin filaments together. Furthermore, we 
did not observe that recombinant SPN protein would stabilize or de-stabilize actin 
filaments in spontaneous or cofilin-induced depolymerisation assay in vitro (I, Fig. 
S3H-I). 
5.1.4 The role of SPN-actin interaction in integrin activity 
and focal adhesions 
To confirm that the SPN Q37A/R38A mutant is only deficient in actin binding, and 
not in integrin inhibition, we employed a FACS-based integrin activity assay that 
measures the level of integrin activation relative to total cell surface β1-integrins. In 
our previous publication, we showed, using the same experimental setting, that 
expression of GFP SPN WT, but not R12C, inhibited integrin activity in CHO cells 
(Lilja et al., 2017). Interestingly, here we observed that while expression of GFP 
SPN WT reduced integrin activity, GFP SPN Q37A/R38A expressing cells had even 
lower integrin activity (I, Fig. 4F). Altogether, our data shows that Q37A/R38A point 
mutation only disrupts the actin binding, but retains the integrin inhibitory functions 
of the SHANK3 SPN domain. To study further how actin binding affects interaction 
between the SPN domain and active Rap1, we performed a modified actin co-
sedimentation assay in presence of active, GTP-analogue-loaded Rap1. 
Interestingly, we observed that presence of active Rap1 inhibited interaction between 
the SPN domain and actin (I, Fig. 4G-H, S4G). Addition of active Rap1 reduced 
proportion of actin-bound recombinant SPN protein compared to control sample 
without Rap1 (I, Fig. 4G-H). Taken together, these data indicate that active Rap1 
may compete with actin from binding the SPN domain and that disruption of actin 
binding may even enhance integrin inhibition due to increased availability towards 
sequestering active Rap1.  
In previous work from our group, SHANK3 silencing was shown to increase 
number of nascent adhesions and to reduce average adhesion size (Lilja et al., 2017). 
Here, we observed that in addition to colocalising with actin stress fibers (I, Fig. 3C-
D), GFP SPN WT-expressing cells had very large, vinculin-positive adhesions (I, 
Fig. 4A-B). Taken together, these data suggest that SHANK3 and its SPN domain 
may regulate focal adhesion size and maturation by sequestering active Rap1 and by 
altering thereby recruitment of talin to cytoplasmic tails of integrins. However, focal 
adhesions are also physically connected to actin stress fibers and adhesion size has 
been shown to be regulated by actomyosin contractility (Burridge and Guilluy, 2016; 
Chrzanowska-Wodnicka and Burridge, 1996). Thereby, we wanted to investigate 
how the distinct roles of the SHANK3 SPN domain in actin- and Rap1-binding affect 
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focal adhesions. To address this, we analysed the number and size of focal adhesions 
from cells expressing GFP control, GFP SPN WT, actin-binding deficient GFP SPN 
Q37A/R38A and Rap1-binding deficient GFP SPN R12C. Interestingly, only GFP 
SPN WT induced large focal adhesions, and both Q37A/R38A and R12C remained 
similar to our negative GFP control (I, Fig. 4A-C). The average cell area and 
adhesion count remained unchanged in all conditions (I, Fig. 4A, D-E). Taken 
together, these data indicate that GFP SPN WT interacts with both actin and active 
Rap1 to modulate focal adhesion size and maturation. 
5.1.5 Interaction between the SPN domain and actin is 
regulated by the SPN-ARR fold 
Our data thus far indicates that the SPN domain interacts directly with actin. 
However, imaging of longer SHANK3 fragments (with additional SHANK-
domains) revealed that the presence of the adjacent ARR-domain seemed to interfere 
with the SPN–actin-colocalisation (I, Fig. 2B). The two first N-terminal SHANK3 
domains, SPN and ARR, interact with each other through intramolecular interactions 
(Mameza et al., 2013; Lilja et al., 2017). In addition, this interaction has been shown 
to inhibit SHARPIN and α-fodrin from binding to the SHANK3 ARR domain 
(Mameza et al., 2013). Importantly, this suggests that some of the SPN actin-binding 
surface may be sandwiched between the two domains in longer SHANK3 fragments. 
Therefore, we performed actin co-sedimentation assay with both recombinant SPN 
and SPN-ARR proteins, and observed that while recombinant SPN bound to F-actin 
and was present in the pellet fraction (I, Fig. 2C-D, S2C), SPN-ARR remained in the 
supernatant (I, Fig. 5A, S5C-D) indicating that the SPN-ARR fold interferes with the 
putative actin-binding site.  
We used the available X-ray crystallography data (Cai et al., 2019; Lilja et al., 
2017) to predict potential ways to trigger opening of the SPN-ARR fold. Importantly, 
we identified N52 as potentially critical amino acid residue in the interface between 
the two domains (I, Fig. 5B-C), and mutated it into positively charged arginine to 
reveal additional interaction surfaces at the SPN-ARR interface. Moreover, our 
collaborators performed molecular simulations to detect if N52R point mutation 
would induce conformational changes in the SPN-ARR fold. Interestingly, they 
showed that charge repulsion introduced by the N52R mutation would induce 
opening of the fold, which in the WT protein remained closed in their tested time 
scales (I, Fig. 5D-F). We introduced the N52R point mutation into recombinant SPN-
ARR protein, and strikingly, approximately 90 % of SPN-ARR N52R bound to F-
actin in co-sedimentation assay, while WT did not bind actin (I, Fig. 5I-J). 
Furthermore, when expressed in cells, SPN-ARR N52R-mRFP colocalised very 
strongly with F-actin in microscopy experiments, while most of the SPN-ARR WT 
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localised diffusely in the cytoplasm (I, Fig. 5G-H). These data validate our 
hypothesis that the SPN-ARR fold interferes with actin binding, and the fold opening 
dynamically regulates interaction between the SPN domain and actin. 
5.1.6 The role of SHANK3-actin binding in filopodia 
formation 
While GFP SPN WT colocalises with F-actin in cells, the full-length GFP SHANK3 
is present throughout the cytoplasm with a slight intensification at the plasma 
membrane (I, Fig. 2B). We introduced the actin-binding disrupting Q37A/R38A and 
actin-binding promoting N52R point mutations into full-length GFP SHANK3 to 
study if altered actin binding would also affect SHANK3 localisation in cells. Both 
GFP SHANK3 WT and the Q37A/R38A mutant localised similarly throughout the 
cell (I, Fig. 6A-B), whereas N52R mutant had a strikingly different localisation (I, 
Fig. 6A). GFP SHANK3 N52R was heavily concentrated in the cell center and 
almost absent from the cell periphery and cell edges. Furthermore, GFP SHANK3 
N52R overlapped with F-actin staining in the center of the cell (I, Fig. 6A). This 
suggests that the N52R point mutation forces the SPN-ARR fold to stay open 
promoting interaction between full-length SHANK3 and F-actin. 
Filopodia are regulated by actin dynamics, bundling and polymerisation as well 
as integrin activity. As we observed that interaction with both actin and active Rap1 
was required for regulation of focal adhesions (I, Fig. 4A-E), we wanted to 
investigate whether that would also have a role in regulation of filopodia formation. 
Intriguingly, we observed that Rap1-binding deficient R12C and, based on our 
findings with the SPN and ARR domains, actin-binding deficient Q37A/R38A and 
actin-binding dominant active N52R were all unable to inhibit formation of Myo10-
positive filopodia (I, Fig. 6E-F). Importantly, only GFP SHANK3 WT inhibited 
filopodia formation when co-expressed with Myo10-mCherry (I, Fig. 6E-F). Taken 
together, these data indicate that SHANK3 needs to be able to interact dynamically 
with both actin and active Rap1 to inhibit filopodia formation. 
5.1.7 Discussion 
In this study, we describe a novel direct interaction between SHANK3 and actin. In 
addition, we mapped that interaction between SHANK3 and actin occurs through the 
less-studied N-terminal SHANK3 SPN domain and showed that interaction between 
the SPN domain and actin is dynamically regulated by SPN-ARR fold opening. 
Importantly, we show that while the binding sites of actin and the other known SPN 
interactor active Rap1 are distinct, the SHANK3 SPN domain may still need to 
interact with both of them in some cellular contexts to regulate for example adhesion 
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size and filopodia formation. This suggests that the actin binding may be a 
scaffolding function critically enabling SHANK3 to coordinate distinct activities in 
cells. 
In our groups previous work, we showed that SHANK3 inhibited cancer cell 
migration and invasion through sequestering active Rap1 and limiting thereby 
integrin activation (Lilja et al. 2017). Importantly, filopodia promote cancer cell 
migration and invasion (Jacquemet, Hamidi, and Ivaska 2015), and number of 
filopodia has been shown to be regulated by integrin activity (Jacquemet et al., 
2016). Moreover, expression of integrin activating talin and constitutively active 
Rap1 promote filopodia formation (Jacquemet et al., 2016; Lagarrigue et al., 2015). 
Consistently, cells plated on anti-β1 integrin antibodies, which lock integrins either 
into active or inactive conformation, exhibited high number of Myo10-positive 
filopodia when integrins were activated, and a low number when integrins were kept 
inactive (Jacquemet et al., 2016). Taken together, observations from our group and 
others highlight the role of integrin-induced filopodia formation in cancer and cell 
migration.  
Here I addressed if expression of integrin-inhibiting SHANK3 regulated 
filopodia formation. As expected, full-length SHANK3 and the active Rap1-
sequestering SPN domain alone reduced the number of Myo10-positive filopodia. 
However, I also discovered that the SPN domain binds actin directly and addressed 
if it contributed to inhibiton of filopodia formation. My data indicate that while both 
actin- and Rap1-binding sites are located in the SPN domain, they are distinct and 
disrupting actin binding does not prevent sequestration of Rap1, and vice versa. My 
flow cytometry assays indicated that the actin-binding deficient GFP SPN 
Q37A/R38A inhibited integrins even more efficiently than SPN WT, which lead me 
to hypothesise that full-length GFP SHANK3 Q37A/R38A would be a very efficient 
inhibitor of filopodia formation as well. However, this was not the case, as GFP 
SHANK3 Q37A/R38A did not reduce the number of filopodia when compared to 
control. My data suggests that SHANK3 needs to interact with both actin- and Rap1 
to inhibit filopodia formation. Currently, it is not clear why this is the case. We do 
not detect WT SHANK3 protein localising to filopodia tips (Guillaume Jacquemet, 
personal communication), suggesting that it might not act directly in filopodia to 
limit active Rap1 availability, but would rather function in the cell body affecting 
the overall pool of active Rap1. In fact, when we compared how GFP SHANK3 WT, 
actin-binding deficient Q37A/R38A, actin-binding dominant active N52R and Rap1-
binding deficient R12C regulated Myo10-positive filopodia, only WT inhibited 
filopodia formation. Importantly, these findings suggest that dynamic interaction 
between SHANK3 and actin may be necessary in facilitating other SHANK3 
functions. However, it is important to recognize that the SPN domain alone cannot 
be used to replace in the full-length SHANK3 in functional studies, and we have 
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only confirmed changes in SPN-actin binding in shorter SHANK3 fragments. 
Studying actin binding of the full-length SHANK3 is complicated by the fact that it 
is unlikely to be similarly folded when expressed in Escherichia coli, and when 
expressed in mammalian cells, other actin-related SHANK3 interactors complicate 
the result interpretation. While the SPN domain alone is a valuable tool in 
characterizing molecular interactions, its functions may differ in full-length 
SHANK3 where other functional domains and their interactors also affect the protein 
function. 
Although we focus on the role of integrin activity in regulation of filopodia 
formation, the possibility that SHANK3 regulates filopodia formation through its 
other actin-related binding partners remains unexplored. In neurons, SHANK3 has 
been shown to bind to and associate with many proteins that are known as filopodia 
regulators outside the CNS. For example, the SHANK3 PDZ domain binds β-PIX 
(Park et al., 2003), which is a guanosine exchange factor (GEF) for filopodia-
promoting GTPases Cdc42 and Rac1. Furthermore, the SHANK3 PP region binds 
IRSp53 (Bockmann et al., 2002), which also promotes filopodia formation through 
the Arp2/3 complex and as a Cdc42 effector (Lim et al., 2008).  However, as all of 
the above mentioned SHANK3 interactors are known to promote filopodia formation 
in non-neuronal cells rather than inhibit it, and my data shows that the Rap1-
sequestering SPN domain alone is sufficient to inhibit filopodia formation, I 
hypothesise that the inhibitory effect I observed in my experiments, is due to reduced 
integrin activity.  
Firstly, it is important to consider the differences between cell types and 
developmental stages. In neurons, SHANK3 has been identified as an important 
scaffold protein for multiple actin regulators and it is considered to recruit them to 
the PSD and growth cones promoting cytoskeletal development (Bockmann et al., 
2002; Durand et al., 2012; Lim et al., 2008; Naisbitt et al., 1999; Park et al., 2003; 
Sarowar and Grabrucker, 2016; Wang et al., 2019). Importantly, the cellular context 
is thereby very different from cancer cells that I have used in my studies. For 
example, cortactin, which binds to the SHANK3 PP region (Naisbitt et al., 1999), 
has been shown to stabilize filopodia in neuronal growth cones (Yamada et al., 
2013), but in cancer cells it promotes invadopodia formation (Linder et al., 2011). 
Importantly, there is a lack of studies comparing the role of interaction between 
SHANK3 and its actin-related binding partners in the CNS and in non-neuronal cells.  
Secondly, our data suggests that active Rap1 and actin may compete with each 
other from binding the SPN domain. Our in vitro data suggests that presence of 
active Rap1 reduces interaction between purified F-actin and recombinant SPN 
protein. So far, this has only been addressed in the context of the SPN domain 
alone (instead of longer SHANK3 fragments) and with purified proteins, which is 
a very simplistic set-up compared to all factors that are present in the cytoplasm of 
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a cell, such as the other actin regulators SHANK3 is known to interact with. 
However, these data lead me to hypothesise that the SPN domain may regulate 
whether SHANK3 is destined to promote actin polymerization and actin 
remodelling, or if it focuses on regulating bioavailability of active GTPases and 
integrin activity. I hypothesise that when the SPN domain is bound to F-actin, 
SHANK3 may regulate organisation of the actin cytoskeleton by bringing several 
actin regulators together or in close proximity of each other. The assumption that 
SPN-actin binding has a role in scaffolding is also supported by the fact that we 
did not observe SPN-actin interaction to modify the actin itself. We did not observe 
that SPN domain alone would have bundled actin, induced actin polymerization or 
affected actin stability. In turn, when the SPN domain is bound to active Rap1, 
interaction with F-actin and other actin regulators may be suppressed. 
Intriguiginly, excess of active Rap1 has been shown to lead to long and thin 
dendritic spines in neurons (McAvoy et al., 2009; Pak et al., 2001), where as 
SHANK3 has been shown to do the opposite: to promote spine maturation and 
spine head formation through regulation of the actin cytoskeleton (Durand et al., 
2012; Sarowar and Grabrucker, 2016). Therefore, I hypothesise that SHANK3 may 
act as a counterbalance for increased Rap1 activity by sequestering it, bringing it 
to close contact with Rap1-inactivating GTPase activating proteins (GAPs), such 
as spine-associated RapGAP SPAR, that binds to the SHANK3 PDZ domain 
(Spilker et al., 2008). Once active Rap1 is no longer abundant, SHANK3 may 
continue to recruit and scaffold actin regulators promoting spine head enlargement 
and maturation. Taken together, the SPN domain may act as a major switch 
regulating which signalling events and cellular processes SHANK3 participates.  
In this study, we also demonstrated with a proof-of-concept point mutant 
N52R, that SPN-ARR fold opening regulates the SPN-actin interaction. However, 
the exact physiological signal that triggers the fold opening remains to be 
discovered. Post-translational modifications, such as phosphorylation, occurring in 
the close proximity of the interface could potentially induce the fold opening. 
Importantly, phosphorylation of SHANK3 S685, which is located in the SHANK3 
PP domain, has been shown to regulate binding of Abi1 and recruitment of the 
WAVE complex to the PSD promoting thereby actin polymerisation. Furthermore, 
S685I has been identified as an ASD-linked patient mutation highlighting 
importance of both post-translational modifications in SHANK3 function and the 
importance of SHANK3 mediated actin re-organisation (Wang et al., 2019). 
However, the only so far reported phosphorylation site in the N-terminal SHANK3 
identified in several phosphoproteome screens is Y122 (Phosphosite.org database 
& (Wang et al. 2019)). As Y122 is not localised close to the SPN-ARR interface, 
we did not see it as an obvious candidate for triggering the SPN-ARR fold opening. 
However, the possible role of phosphorylation and other post-translational 
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modifications as regulators of the SPN-ARR fold remains to be studied. 
Furthermore, the role of N-terminal SHANK3 patient mutations (Table 1.) in the 
SPN-ARR fold opening and actin binding remains to be investigated. Here, I found 
that R12C does not disrupt interaction with actin, and we know based on previous 
observations that another autism-linked patient mutation, L68P, disrupts the SPN-
ARR fold severely making it non-functional (Lilja et al. 2017; Mameza et al. 
2013). Altogether, our data indicate that dynamic interaction between SPN and 
actin is essential, but the physiological signalling events that trigger the fold 
opening are yet to be identified. 
Taken together, this study describes a novel, direct interaction between the 
SHANK3 SPN domain and F-actin. Intriguingly, we demonstrate that the actin-
binding site is cryptic and its availability is regulated by the SPN-ARR fold opening. 
Furthermore, our data indicates that the SPN domain may serve as an interaction 
hub, that determines whether SHANK3 participates in Rap1 and integrin signalling 
or in remodelling of the actin cytoskeleton. Importantly, our data reveals new 
information of SHANK3 function that may create a platform for further 
investigations of the role of SHANK3 in cancer cell migration and dendritic spine 
morphogenesis. Importantly, understanding how interaction between the SHANK3 
SPN domain and actin and/or active Rap1 and discovering ways how to control it 
may lead to identification of novel therapeutic targets in both cancer and 
neurological disorders.  
5.2 Identification of novel SHARPIN interactors (II) 
SHARPIN has been shown to bind multiple proteins, such as SHANKs (Lim et al., 
2001), the LUBAC complex (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et 
al., 2011), caspase-1 (Nastase et al., 2016) and PTEN (He et al., 2010) (Figure 10.), 
and it is thought to mediate and modulate their function as an adaptor protein. 
Importantly, our group also identified SHARPIN as an integrin inhibitor (Rantala et 
al., 2011). However, we are far from complete understanding of SHARPIN-mediated 
signalling. With this project, we set out to further characterize SHARPIN function 
and identify new SHARPIN interactors. Therefore, our collaborators performed a 
mass spectrometry screen to identify SHARPIN-linked cellular processes and 
potential novel interactors of SHARPIN. In order to identify especially proteins that 
would interact with SHARPIN in an integrin-dependent manner, our collaborators 
performed the screen with both GFP SHARPIN-expressing cells in suspension 
(without engaging integrins to the ECM) and with adherent cells plated on 
fibronectin. However, there was no major differences between the data sets from 
cells in suspension or adherent cells (II, Fig. S1A-B, Table S1). Importantly, the 
mass spectrometry screen identified known SHARPIN interactors, such as the 
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LUBAC complex members HOIP (RNF31) and HOIL-L1 (RBCK1), validating the 
quality of the screen (II, Fig. S1C). The identified hits were further classified based 
on confidence of the hit, and furthermore, the hits were divided into clusters based 
on gene ontology and biological processes they associate with (II, Fig. 1A, Table S2) 
(Huang et al., 2009; Merico et al., 2010). The gene ontology analyses identified 
SHARPIN to associate with many cytoskeletal regulators (II, Fig. 1B-C, Table S3). 
Importantly, two members, ArpC2 and ArpC5, of the seven subunit Arp2/3 complex 
were amongst the identified hits (II, Fig. 1C). Encouraged by presence of several 
Arp2/3 subunits in the list, we decided to confirm interaction between SHARPIN 
and the Arp2/3 complex to validate our mass spectrometry-based SHARPIN 
interactome.  
5.2.1 Establishment of interaction between SHARPIN and 
the Arp2/3 complex 
After confirming the interaction between SHARPIN and the Arp2/3 complex with 
different techniques, such as proximity ligation assay (II, Fig. 2A, S2A-B) and co-
immunoprecipitation assays with both cell extracts (II, Fig. 2B-C) and recombinant 
or purified proteins (II, Fig. 2F, S2F), we characterised which domain of SHARPIN 
would be the interaction site. SHARPIN has three functional domains, the N-
terminal PH domain, the central UBL domain and the C-terminal NZF domain 
(Figure 10.). Importantly, our group’s earlier work identified the UBL domain as an 
interaction site for integrin α-tail and the LUBAC complex. Furthermore, the binding 
sites were shown to be partially overlapping, but mutually exclusive (De Franceschi 
et al., 2015). We used fluorescence resonance energy transfer (FRET) combined with 
fluorescence lifetime imaging microscopy (FLIM) and GFP co-immunprecipitation 
assay to map interaction between SHARPIN and the Arp2/3 complex to occur 
through the UBL domain (II, Fig. 3A-B). In our previous work, we modelled 
potential binding surfaces in the UBL domain that were evolutionary conserved in 
similarly folded proteins, and created six single or double point mutants by replacing 
identified amino acids with alanines (De Franceschi et al., 2015). We used FRET-
FLIM to study energy transfer between GFP SHARPIN WT and mutant constructs 
and Arp3-mRFP, and detected that three of our GFP SHARPIN mutants, 
V240A/L242A, V267A and L276A, exhibited reduced interaction with Arp3-mRFP 
(II, Fig. 3C). As we found in our groups earlier work that V267A and L276A had 
also altered interaction with α-integrins and the LUBAC complex, we selected 
V240A/L242A as our tool to study specifically the role of SHARPIN-Arp2/3 
interaction. 
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5.2.2 SHARPIN localisation to lamellipodia is not specific, 
but secondary to increased cytoplasm in membrane 
ruffles 
Once we had confirmed the interaction between SHARPIN and the Arp2/3 complex, 
we employed different microscopy techniques to study how interaction between 
SHARPIN and the Arp2/3 complex affects cell morphology and cytoskeletal 
structures (II, Fig. 4A-C). Furthermore, we wanted to study if SHARPIN and the 
Arp2/3 complex colocalise in these structures (II, Fig. S4A-C). The Arp2/3 has a 
pivotal role in catalysing formation of branched actin network at the leading edge of 
the cell and it has been shown to localise in lamellipodia (Suraneni et al., 2012; 
Welch et al., 1997). Interestingly, SHARPIN has also been reported to localise at the 
cell edge (Rantala et al., 2011). To study this further, we performed live-cell imaging 
with GFP SHARPIN-expressing NCI-H460 non-small lung adenocarcinoma cells. 
We observed that GFP SHARPIN-expressing cells had typically multiple 
lamellipodia-like ruffles, and GFP-SHARPIN localised especially in these structures 
(II, Movie S1). We also imaged SHARPIN- and Arp3-silenced (disrupts the entire 
Arp2/3 complex) cells expressing mEmerald-Lifeact (to visualize actin) with total 
internal reflection fluorescence microscopy (TIRF) to determine their contribution 
to actin dynamics (II, Movie S2-4). Importantly, while control silenced cells were 
polarized and they had typically multiple, lamellipodia-like structures, both 
SHARPIN- and Arp3-silenced cells had a round shape and they lacked lamellipodia. 
Furthermore, both SHARPIN- and Arp3-silenced cells exhibited more filopodia, 
which has been observed earlier in response to Arp2/3 downregulation (II, Movie 
S2-4) (Beli et al., 2008; Wu et al., 2012). 
We observed that both endogenous SHARPIN and Arp2 localised at 
lamellipodia-like structures and at the leading edge when stained from fixed HeLa 
cervical cancer cells and NCI-H460 cells (II, Fig. S4A, C). However, our further 
analysis indicated that SHARPIN localisation at the leading edge may not be specific 
to the Arp2/3 complex. We employed line scans to plot SHARPIN, Arp2 and 
cytoplasmic protein p65 (an irrelevant protein for lamellipodia formation used as a 
negative control) intensities across the lamellipodia. These revealed that SHARPIN 
and our negative control p65 had similar intensity plots suggesting that the intensity 
peak at the leading edge might be unspecific (II, Fig. S4C-D). Furthermore, we did 
not observe SHARPIN staining at the leading edge of U2OS cells, whereas Arp2 
peaked strongly at their lamellipodia (II, Fig. S4E). Taken together, these findings 
raised a question whether SHARPIN localisation at the leading edge would be due 
to cell shape and thickness of the cytoplasm. For example, NCI-H460 cells make 
quite thick ruffles at the leading edge, whereas U2OS cells are very flat and they 
have only a little cytoplasmic thickening at lamellipodia. To study further if 
SHARPIN was recruited to lamellipodia primarily together with the Arp2/3 complex 
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or if it localises there due to cytoplasmic thickening, we employed fluorescence 
recovery after photobleaching (FRAP) live-cell imaging. Importantly, the Arp2/3 
complex members have been shown to recover at lamellipodia after fluorescent 
photobleaching starting from the cell edge, in a similar manner with retrograde actin 
treadmilling (Lai et al., 2008). We bleached similar rectangular areas across 
lamellipodia of NCI-H460 cells that had thick ruffles. As we anticipated, we could 
not observe any particular direction in the recovery of GFP SHARPIN, but it 
recovered very rapidly and diffusely (II, Fig. S4F). Taken together, these data 
indicate that SHARPIN localisation at the leading edge may be dependent on other 
factors, such as amount of cytoplasmic thickening at the leading edge, rather than 
association with the Arp2/3 complex. 
5.2.3 SHARPIN supports Arp2/3-mediated lamellipodia 
formation 
As we observed, with live-cell imaging, that SHARPIN-silenced cells were similar 
to Arp3-silenced cells, and they both lacked lamellipodia-like structures (II, Movie 
S3-4), we wanted to study further if SHARPIN promoted Arp2/3-mediated 
lamellipodia formation. To address this, we quantified F-actin- and cortactin-
positive lamellipodia from control-, SHARPIN- and Arp3-silenced NCI-H460 cells. 
Similarly to what we observed with live-cell imaging, both SHARPIN- and Arp3-
silenced cells were mostly round and they had significantly reduced number of 
lamellipodia-like ruffles (II, Fig. 4A, S5A, D). Furthermore, we quantified 
lamellipodia from HOIP-silenced cells to distinguish whether SHARPIN promotes 
lamellipodia formation specifically due to interaction with the Arp2/3 complex, or 
do also SHARPINs other roles, such as the LUBAC complex, modulate lamellipodia 
formation. Importantly, HOIP-silencing did not inhibit lamellipodia formation 
suggesting that lack of lamellipodia, caused by downregulation of SHARPIN, would 
be due to interaction with the Arp2/3 complex (II, Fig. 4A). Furthermore, we 
established two SHARPIN KO cell lines from single cell clones using CRISPR. 
Consistently, these SHARPIN KO cell lines exhibited significantly reduced number 
of lamellipodia (II, Fig. 4B, S5C). Importantly, we were able to rescue lamellipodia 
formation in SHARPIN-silenced and SHARPIN KO NCI-H460 cell lines by re-
expressing GFP SHARPIN WT (II, Fig. 5A-B). Furthermore, we showed that our 
previously identified LUBAC-binding mutants (De Franceschi et al., 2015) rescued 
the lamellipodia formation similarly to GFP SHARPIN WT, but the Arp2/3-binding 
deficient GFP SHARPIN V240A/L242A did not induce lamellipodia formation in 
SHARPIN-depleted cells (II, Fig. 5A-B). Altogether, our findings indicate that 
SHARPIN promotes Arp2/3-mediated lamellipodia formation indepent of the 
LUBAC complex. 
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5.2.4 The role of SHARPIN in lamellipodia-driven cell 
migration 
The Arp2/3 complex has an important role in lamellipodial migration, and Arp2/3-
depleted cells lack a strong leading edge and migrate inefficiently (Suraneni et al., 
2012; Wu et al., 2012). Thereby, we performed a wound healing assay with silenced 
HeLa cells. However, while Arp3-silenced samples had significantly wider wounds 
36 h post wounding, SHARPIN silenced samples exhibited similar wound healing 
speed with control silenced samples (II, Fig. S6C). This suggests that lack of 
SHARPIN may promote wound healing through altering function of its other binding 
partners, such as through increased integrin activity. To address how interaction 
between SHARPIN and the Arp2/3 complex specifically modulates cell migration, 
we performed a random migration assay where we rescued SHARPIN null mouse 
embryonic fibroblasts isolated from cpdm mice (cpdm MEFs) with re-expression of 
GFP control, GFP SHARPIN WT and the Arp2/3-binding deficient GFP SHARPIN 
V240A/L242A. We tracked random migration of single cells overnight, and showed 
that expression of both GFP SHARPIN WT and V240A/L242A promoted relative 
migration speed compared to cells expressing GFP control. However, rescue with 
GFP SHARPIN WT was slightly more efficient than rescue with V240A/L242A (II, 
Fig. 6A-B). Taken together, these observations indicate that SHARPIN modulates 
cell migration, but it may be only partially mediated by Arp2/3-driven lamellipodia 
formation. 
5.2.5 Discussion 
Since its original discovery (Lim et al., 2001), the role of SHARPIN has been mostly 
studied in the context of NF-κβ-signalling and the LUBAC complex (Gerlach et al., 
2011; Ikeda et al., 2011; Tokunaga et al., 2011). However, SHARPIN has also been 
identified as a binding partner for various other proteins (He et al., 2010; Nastase et 
al., 2016; Park et al., 2016; Rantala et al., 2011), that do not appear to be connected 
with the LUBAC complex, or each other. Our study contributes to this list by 
identifying multiple potential SHARPIN interactors. Furthermore, our data indicates 
that SHARPIN interacts with the Arp2/3 complex and influences Arp2/3-driven 
processes in cells without any obvious links to other established SHARPIN 
functions.  
We observed with different experiments and in different cell lines that SHARPIN 
promotes lamellipodia formation. However, the exact mechanism how SHARPIN 
promotes Arp2/3-mediated lamellipodia formation remains unclear. Our data 
indicates that downregulation of SHARPIN abolishes lamellipodia formation 
similarly to Arp3 silencing (Suraneni et al., 2012; Wu et al., 2012). In addition, the 
Arp2/3-binding deficient GFP SHARPIN V240/L242A could not rescue 
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lamellipodia formation, in contrast to GFP SHARPIN WT. Furthermore, silencing 
of SHARPINs other binding partners, such as HOIP, did not affect the lamellipodia 
formation. Taken together, these data indicate that SHARPIN promotes lamellipodia 
formation in an Arp2/3-dependent manner. However, while we showed that 
recombinant SHARPIN protein binds the purified Arp2/3 complex, we did not 
observe that recombinant SHARPIN would promote Arp2/3-mediated actin 
polymerization in a gold-standard pyrene polymerization assay (II, Fig. 2G). This 
suggests that SHARPIN may need additional factors to promote Arp2/3 activation, 
or that SHARPIN may promote lamellipodia formation by bringing the Arp2/3 
complex together with another protein that promotes Arp2/3 function.  
Interestingly, our SHARPIN interactome identified also other Arp2/3-related 
proteins, such as Arpin (Dang et al., 2013; Gorelik and Gautreau, 2015), growth 
factor receptor-bound protein 2 (Grb2) (Giubellino et al., 2008), and Rho GTPases 
Cdc42 and Rac1 (Ridley, 2011) as potential SHARPIN interactors. This suggests 
that SHARPIN could promote Arp2/3-mediated lamellipodia formation through 
bringing Arp2/3 activating factors in contact with the Arp2/3 complex, or by 
sequestering Arp2/3 inhibiting factors. Furthermore, my data shows that SHARPIN-
silenced cells have a slow response to serum-stimulated lamellipodia formation (II, 
Fig. 4C), indicating that SHARPIN could indeed promote growth factor-mediated 
response of the Arp2/3 complex. However, the possibility that SHARPIN promotes 
Arp2/3 activation by recruiting other factors awaits to be investigated.  
In addition, SHARPIN has an important role in ubiquitin signalling, as it is 
known to bind ubiquitin through its C-terminal NZF domain (Ikeda et al., 2011), and 
participate in the LUBAC E3 ubiquitin ligase complex through its UBL domain 
(Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011). The potential role of 
SHARPIN in other E3 ligase complexes has not been studied while there are 
indications that it could also promote ubiquitinylation of its binding partners 
independent of the LUBAC complex (De Melo et al., 2014). However, it is not clear 
whether SHARPIN-mediated ubiquitinylation has a role in the lamellipodia 
formation, and there are no reports that would describe the LUBAC complex 
members localising at lamellipodia. Studies describing the role of ubiquitinylation 
in regulation of the actin cytoskeleton remain scarce, but interestingly, Arp2/3 
activators WAVE1 (Jessick et al., 2013) and WAVE2 (Huang et al., 2009) have been 
shown to be regulated by ubiquitinylation linking ubiquitin signalling to actin 
polymerization. Furthermore, E3 ubiquitin ligase complexes have been shown to 
regulate endosomal actin assembly (Hao and Potts, 2014) highlighting the role of 
ubiquitinylation and different E3 ubiquitin ligase complexes in cytoskeletal 
regulation. However, both the role of SHARPIN in other E3 ligase complexes and 
the role of E3 ligases in regulation of the actin cytoskeleton await for further 
characterization. Another possible theory how SHARPIN could promote Arp2/3 
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function is by increasing its stability, as we observed that also Arp3 protein levels 
were slightly reduced in SHARPIN-silenced cells.  
We were not able to fully decipher how SHARPIN-Arp2/3 interaction regulates 
cell migration. Importantly, addressing the role of SHARPIN in cell migration is 
greatly complicated by the fact that it also regulates cell migration through regulation 
of integrin activity (Pouwels et al., 2013; Rantala et al., 2011). I observed that while 
Arp3-silencing expectedly reduced wound closure in scratch wound assay, 
SHARPIN-silenced cells healed the wound similarly to control cells. This is in line 
with reports showing that silencing of SHARPIN (Rantala et al., 2011) and another 
integrin inhibitors SHANK1 and SHANK3 promotes migration velocity (Lilja et al., 
2017). Importantly, our data suggests that integrin- and Arp2/3-related SHARPIN 
functions would be distinct. Treatment with an Arp2/3-inhibitor CK666 (Nolen et 
al., 2009) abolished interaction between SHARPIN and Arp2, but did not interfere 
with SHARPIN-α2-integrin interaction in a PLA assay (II, Fig. S3A-B). 
Furhtermore, CK666 treatment did not reduce activity of cell surface β1-integrins in 
a FACS assay (II, Fig. S3E). One possible way to study the role of SHARPIN-Arp2/3 
in migration would be to balance integrin activation levels in SHARPIN-silenced 
and control cells by plating them on poly-L-lysine coating that does not promote 
integrin-mediated signalling, or on antibodies that lock integrins either in active or 
inactive conformation (Jacquemet et al., 2016). Importantly, actin polymerisation 
and adhesion assembly are highly interdependent in migrating cells, and thereby it 
is challenging – and possibly even physiologically less important – to investigate 
them exclusively in case of SHARPIN. 
Taken together, our study highlights that SHARPIN has a role as an adaptor 
protein in multiple different cellular contexts and SHARPIN function is not limited 
to integrin- and LUBAC-mediated signalling. Moreover, we identify a long list novel 
potential SHARPIN interactors, and characterise how SHARPIN promotes 
lamellipodia formation through the Arp2/3 complex independent of regulation of 
integrin activity and LUBAC function. Importantly, our SHARPIN interactome 
opens a door for multiple other investigations regarding the role of SHARPIN in 
different biological processes.  
5.3 Investigation of reasons and outcomes of 
increased integrin activity in the epidermis of 
SHARPIN null cpdm mice (III) 
Earlier work from our group identified SHARPIN as an integrin inhibitor. 
Importantly, SHARPIN binds to integrin α-tail preventing thereby recruitment of 
integrin activators to integrin β-tail (Rantala et al., 2011). Spontaneous SHARPIN 
null cpdm mice (Sharpincpdm/cpdm) have been identified earlier, and importantly, they 
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suffer from chronic proliferative dermatitis, hence the abbreviation cpdm (Seymour 
et al., 2007). In our previous work, we observed that active β1-integrin levels were 
elevated in skin sections from Sharpincpdm/cpdm mice compared to WT samples 
(Rantala et al., 2011). Our findings are in line with report showing that integrin β1-
overexpression leads to psoriasis-like skin phenotype in mice (Carroll et al., 1995). 
However, the increased overall inflammation and epidermal thickening due to 
keratinocyte proliferation has also been linked to SHARPIN’s role in the NF-κβ-
signalling mediating LUBAC complex and sensitization of cells to TNF-induced cell 
death and inflammation (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 
2011). Therefore, the role of increased integrin activity in the cpdm skin phenotype 
has remained ambiguous. 
5.3.1 Integrin activity is elevated also in epidermis of Tnfr1-/- 
Sharpincpdm/cpdm mice 
To address, whether the increased integrin activity in Sharpincpdm/cpdm epidermis is 
caused by SHARPIN depletion or if it is secondary to augmented TNF-induced cell 
death and inflammation, we used a TNF-receptor (TNFR) null Tnfr1-/- 
Sharpincpdm/cpdm double knockout (KO) mouse strain. Tnfr1-/- Sharpincpdm/cpdm mice do 
not suffer from proliferative dermatitis and they lack most of the systemic 
inflammation phenotypes (Kumari et al., 2014; Rickard et al., 2014). In line with 
earlier observations, we found that the skin of Tnfr1+/+ Sharpincpdm/cpdm mice was 
significantly thicker, indicating inflammatory hyperproliferation (Kumari et al., 
2014; Rickard et al., 2014). Furthermore, the active β1-integrin staining (9EG7) was 
also suprabasally present in the epidermis (III, Fig. 1A) (Rantala et al., 2011) while 
in healthy tissues it should be confined to the basal keratinocyte layer (Hotchin et 
al., 1993, 1995; Watt, 2002). In contrast, skin sections from Tnfr1-/- Sharpincpdm/cpdm 
mice were of normal thickness, healthy looking and the active β1-staining was 
limited to the basal layer (III, Fig. 1A). Moreover, we confirmed also with keratin 
14- (a keratinocyte marker) and integrin α6-staining that integrins were only 
expressed in the basal layer of Tnfr1-/- Sharpincpdm/cpdm epidermis (III, Fig. 1B). 
We used a FACS-based assay to further analyse the integrin activation 
specifically in keratinocytes. We isolated cells from the skin and gated out all other 
residual cell types, such as endothelial cells (positive for CD31, Platelet And 
Endothelial Cell Adhesion Molecule 1 (PECAM1)) or leukocytes (positive for 
CD45, Protein Tyrosine Phosphatase, Receptor Type C (PTPRC)), and included only 
cells positive for α6-integrin (CD49f) labelling (III, Fig. 1C). The α6-integrin-
positive cells were further analysed for active (9EG7) and total (HMβ1–1) β1-
integrin staining. Importantly, our data indicates that integrin activity was 
significantly increased in Tnfr1-/- Sharpincpdm/cpdm keratinocytes compared to 
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keratinocytes isolated from Tnfr1-/- Sharpin+/? mice. As expected, Tnfr1+/? 
Sharpincpdm/cpdm keratinocytes exhibited even higher integrin activity compared to 
cells from double KO mice (III, Fig. 1D). In addition, the total integrin β1 levels 
were slightly, but not significantly, increased in Tnfr1+/+ Sharpincpdm/cpdm mice (III, 
Fig. 1E). Altogether, these data indicate that lack of SHARPIN increases integrin 
activity in epidermal keratinocytes even in absence of inflammation (such as in 
Tnfr1-/- Sharpincpdm/cpdm mice), but integrin activity increases also secondary to 
inflammation (such as in Tnfr1+/+ Sharpincpdm/cpdm mice).  
5.3.2 Integrin β1 function-blocking antibody treatment 
reduces hyperproliferation of Tnfr1+/? Sharpincpdm/cpdm 
cells 
As integrin function-blocking therapies have been reported to ameliorate psoriasis-
like hyperproliferative dermatitis (Conrad et al., 2007; Ley et al., 2016), we tested if 
integrin β1 function-blocking antibody treatment would attenuate the Sharpincpdm/cpdm 
skin phenotype. However, while the antibody treatment reduced epidermal 
thickening and hyperproliferation (III. Fig. 2A-B), it did not reduce infiltration on 
inflammatory cells in the Sharpincpdm/cpdm skin (III. Fig. 3A-F). In addition, we 
developed a method to isolate primary keratinocytes from mouse skin for cell 
culture. The purity of the isolated population was controlled by western blot and 
staining for keratin-14 and vimentin (a fibroblast marker) (III, Fig. 2F, S1E). In line 
with our other observations, treatment with integrin β1 function-blocking antibody 
reduced relative keratinocyte proliferation also in isolated cells (III, Fig. 2G-H). 
However, the treatment reduced proliferation also in Sharpin+/? control cells (III, Fig. 
2H). Taken together, these data indicate that integrin activity is increased in Tnfr1-/- 
Sharpincpdm/cpdm skin even in absence of inflammation, and that inhibition of integrin 
activity partly rescues the epidermal hyperproliferation phenotype in Sharpincpdm/cpdm 
skin and in isolated keratinocytes. Moreover, as treatment with β1 function-blocking 
antibody inhibits the hyperproliferation, but does not reduce infiltration of 
inflammatory cells in Sharpincpdm/cpdm skin, the chronic inflammation phenotype is 
more likely due to LUBAC function than integrin activity.  
5.3.3 Discussion 
As a multifunctional adaptor protein, SHARPIN is known to bind directly and 
modulate the function of many other proteins. The most well-established interaction 
partners of SHARPIN are integrins (Gao et al., 2019; Rantala et al., 2011; Kasirer-
Friede et al., 2019) and the LUBAC complex (Gerlach et al., 2011; Ikeda et al., 2011; 
Tokunaga et al., 2011). SHARPIN null cpdm mice suffer from hyperproliferative 
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dermatitis and multiorgan inflammation, which have been linked to aberrant NF-κB-
signalling and induced TNF-mediated apoptosis as a consequence of abrupted 
LUBAC function (Ikeda et al., 2011; Tokunaga et al., 2009, 2011). However, it has 
remained unclear how increased integrin activity contributes to the Sharpincpdm skin 
phenotype, or is it just a secondary outcome of the systemic inflammation. 
Both lack of SHARPIN and another LUBAC-complex member HOIL-1L has 
been separately shown to sensitize cells to TNF-induced cell death. However, Hoil-
1l-depleted cells exhibit more moderate phenotypes compared to Sharpincpdm-cells, 
and most importantly, Hoil-1l KO mice do not exhibit similar hyperproliferative 
dermatis as Sharpincpdm mice (Ikeda et al., 2011; Tokunaga et al., 2009, 2011). While 
especially interaction with the LUBAC complex has been proposed to underlie the 
skin phenotype of Sharpincpdm mice by sensitizing the cells to TNF-induced cell 
death (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011), our group 
showed that levels of active β1-integrin are elevated in the epidermis of Sharpincpdm 
mice. Furthermore, integrin expression was not confined to the basal layer of the 
epidermis in Sharpincpdm mice (Rantala et al., 2011), as it is expected to be under 
normal conditions. Encouraged by reports describing similar phenotype of integrin 
β1-overexpressing mouse strain (Carroll et al., 1995), we hypothesised that increased 
integrin activity would also contribute to the Sharpincpdm mice skin phenotype, in 
addition to the LUBAC complex. Here, we were able to show that while increased 
inflammation increases integrin activity in the skin, we also detect increased integrin 
β1-activity in almost completely inflammation free Tnfr1-/- Sharpincpdm/cpdm mice. 
Furthermore, others have shown that integrin function blocking antibodies 
ameliorate psoriasis-like phenotypes in human (Ley et al., 2016) and mice (Conrad 
et al., 2007). In line with these observations, we see reduction in epidermal 
hyperproliferation upon treatment with integrin β1 function-blocking antibody. 
However, as the antibody treatment is not sufficient to reduce infiltration of 
inflammatory cells in the skin tissue, these findings suggest that while increased 
integrin activity contributes to the cpdm phenotype, it does not explain it solely. 
Moreover, other SHARPIN interactors, such as the LUBAC complex, contribute at 
least to the development of the systemic inflammation. 
In addition to binding integrins and the LUBAC complex members, SHARPIN 
is also known to interact with multiple other proteins, which may also contribute to 
the Sharpincpdm skin phenotype. For example, SHARPIN has been shown to directly 
bind and inhibit inflammation and cell death-driving caspase-1 in a LUBAC-
independent manner. Furthermore, Sharpincpdm mice have been shown to exhibit 
reduced survival upon sepsis, while caspase-1 inhibition ameliorated the phenotype 
(Nastase et al., 2016). Another study has shown that caspase-1 and -11 are highly 
upregulated in Sharpincpdm skin sections. Interestingly, induction of caspase-1 and -
11 were observed in the Sharpincpdm skin already before the actual onset of the 
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dermatitis. Moreover, caspase-1 and -11 depletion delayed onset of the dermatitis, 
but onset of systemic inflammation remained unchanged indicating that caspase-1 
and -11 may contribute to the Sharpincpdm skin phenotype independent of the 
LUBAC-complex-mediated systemic inflammation (Douglas et al., 2015). 
Furthermore, caspase-1 and -11 participate in inflammasome signalling, that is 
activated upon innate immune responses to tissue damage, invading micro-
organisms and metabolic perturbations. In addition to downregulation of caspase-1 
and -11, genetic ablation of another inflammasome sensor, leucine-rich repeat 
(LRR)-containing protein 3 (NLRP3), also alleviated the Sharpincpdm skin phenotype 
(Douglas et al., 2015). Altogether, these findings suggest that responses to tissue 
damage and inflammasome activation may be altered in Sharpincpdm mice, and they 
could also contribute to the cpdm phenotype. Intriguingly, as NLRP3 inflammasome 
has been shown to be activated downstream of β1 integrins upon micro-organism 
infection integrins (Jun et al., 2012; Thinwa et al., 2014), it is tempting to speculate 
that the increased integrin activity and inflammasome activation in Sharpincpdm mice 
are connected. 
There is a lack of studies describing the role of SHARPIN in development and 
other diseases than dermatitis as Sharpincpdm/cpdm mice develop severe dermatitis 
early on, they need to be sacrificed already when they are 8-week old. Importantly, 
Tnfr1-/- Sharpincpdm/cpdm mice that do not exhibit signs of major inflammation, have a 
longer lifespan and they may provide a novel way to study the role of SHARPIN in 
other developmental stages and in other diseases, such as cancer. Interestingly, 
SHARPIN upregulation and gene amplification have been shown to associate with 
multiple human cancers (De Melo and Tang, 2015; Li et al., 2015; Tamiya et al., 
2018; Tanaka et al., 2016; Zhang et al., 2014; Zhuang et al., 2017). Therefore, the 
dermatitis-free Tnfr1-/- Sharpincpdm/cpdm mice may be a valuable tool in cancer 
research. Furthermore, Tnfr1-/- Sharpincpdm/cpdm and Sharpincpdm/cpdm mice may be used 
as a model system in psoriasis studies and in investigations of the role of integrin 
activity in skin disorders. 
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6 Summary 
The purpose of the work presented in this thesis was to further characterise two 
proteins that our group has identified as inhibitors of integrin cell adhesion receptors: 
SHANK3 (Lilja et al., 2017) and SHARPIN (Rantala et al., 2011). Importantly, as 
there is an immense amount of crosstalk between cell adhesion and the actin 
cytoskeleton, we wanted to investigate if and how SHANK3 and SHARPIN also 
regulate the actin cytoskeleton and cytoskeletal structures, such as filopodia and 
lamellipodia. Furthermore, we set out to unravel a question that was left unanswered 
in our previous work: does increased integrin activity contribute to the 
hyperproliferative dermatitis phenotype of SHARPIN null cpdm mice, or is it driven 
by the role of SHARPIN in the LUBAC complex and NF-κβ-signalling. Here, we 
identify novel roles for SHANK3 and SHARPIN in regulation of the actin 
cytoskeleton in cells, and characterise the role of SHARPIN-mediated integrin 
inhibition in vivo. 
6.1 SHANK3 is a novel actin-binding protein that 
regulates filopodia formation 
We set out to investigate the role of SHANK3 in filopodia formation through 
inhibition of integrins. However, we found that instead of regulating filopodia 
exclusively through integrins, SHANK3 has previously unappreciated actin-binding 
activity. SHANK3 binds actin directly with its N-terminal SPN domain, which was 
previously shown to regulate integrin activation by sequestering active Rap1 (Lilja 
et al., 2017). Through site-directed mutagenesis, biochemistry and cell imaging, we 
mapped the Rap1- and actin-binding sites in the SPN domain and demonstrated that 
they are distinct. Furthermore, we showed that the two N-terminal SHANK3 
domains, SPN and ARR are folded in a way that covers the actin-binding site in the 
interface between the two domains. Thereby, opening of the SPN-ARR fold 
dynamically regulates the interaction between SHANK3 and actin. Importantly, we 
showed that while the SPN domain can interact with active Rap1 and actin 
separately, the full-length SHANK3 may require ability to interact dynamically with 
both active Rap1 and actin to inhibit filopodia formation. Importantly, our data 
indicates that SHANK3 may have an important role in regulation of both cell 
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adhesion and the actin cytoskeleton as it balances between scaffolding its multiple 
binding partners, such as Rap1, actin and actin regulatory proteins. Importantly, our 
data indicate that the N-terminal SPN domain may act as a switch that determines in 
which cellular processes and signalling cascades SHANK3 participates. These novel 
roles of SHANK3 may have implications in both neuronal and non-neuronal cells, 
as cell adhesion and actin re-organization have pivotal role in both cancer cell 
migration and dendritic spine morphogenesis. Furthermore, understanding how 
interaction between SHANK3 and its different binding partners can be manipulated 
may lead to identification of novel therapeutic approaches to treat ASD and cancer.  
6.2 SHARPIN promotes lamellipodia formation 
In this part of the thesis, we presented the first mass spectrometry-based SHARPIN 
interactome and demonstrate that it associates with a versatile set of proteins 
implicated in many different biological processes. We observed that several putative 
SHARPIN interactors associate with cytoskeletal regulation, and confirmed a direct 
interaction between SHARPIN and the Arp2/3 complex. Our data indicate that 
SHARPIN promotes Arp2/3-dependent formation of branched actin networks at the 
leading edge of the cell. Furthermore, we mapped that the interaction with the Arp2/3 
complex occurs through same SHARPIN domain (the UBL domain) to which also 
α-integrins and the LUBAC complex binds. However, we showed that the Arp2/3 
binding site is distinct from them and created an Arp2/3-binding deficient SHARPIN 
mutant. Importantly, we showed that the interaction between SHARPIN and the 
Arp2/3 complex promotes lamellipodia formation independent of the LUBAC-
complex and integrins. These data indicate that the UBL-domain is a central activity 
hub in SHARPIN, but it is unclear how the different UBL-interations and functions 
are regulated or coordinated in cells. As the binding sites for integrins, the LUBAC 
complex and the Arp2/3 complex are all in close proximity, it may be that SHARPIN 
is only able to interact with one of them at the time. Therefore, interaction between 
SHARPIN and its different binding partners could be induced by different cellular 
challenges, such as inflammation, TNF- or growth factor-mediated signalling. 
Furthermore, the possibility that SHARPIN interacts with different proteins in 
spatially distinct locations remains to be studied. Importantly, this study highlights 
that SHARPIN is likely to have multiple functions and interaction partners in 
addition to integrin- and LUBAC-mediated signalling which have been the focus of 
most SHARPIN studies so far. Understanding how SHARPIN interacts with its 
different binding partners in different cellular contexts and different cellular 
locations may improve our understanding of molecular mechanisms driving cancer 
progression and/or inflammation. 
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6.3 SHARPIN-deficiency increases integrin activity 
and keratinocyte proliferation also in absence 
of inflammation 
Several studies have shown that SHARPIN interacts with integrins (Rantala et al., 
2011; Pouwels et al., 2013; Gao et al., 2019; Kasirer-Friede et al., 2019) and is a 
member in the NF-κβ-signalling pathway mediating LUBAC complex (Gerlach et 
al., 2011; Tokunaga et al., 2011; Ikeda et al., 2011). While SHARPIN has been 
shown to inhibit integrins independent of the LUBAC complex in cells, the role of 
SHARPIN-mediated integrin inhibition in vivo has remained more obscure. 
Importantly, SHARPIN null cpdm mice suffer from an inflammatory skin phenotype 
that has been linked to increased TNF-mediated apoptosis due to altered LUBAC 
function. In addition, intergrin activity has been shown to be increased in the 
Sharpincpdm/cpdm skin (Rantala et al., 2011) raising a debate what part of the increased 
integrin activity in these mice is a secondary effect to the overall increased 
inflammation and what is the contribution of the lack of SHARPIN. We addressed 
this by looking specifically into epidermis of cpdm mice. Importantly, we 
distinguished cpdm phenotype features that appear to be more dependent on integrin 
activity or the LUBAC complex, respectively. We showed that while integrin 
activation is partly caused by the general inflammation in cpdm mice, integrin 
activity is also elevated in the absence of inflammation, as shown by simultaneous 
depletion of TNFR1 receptor. Furthermore, while the LUBAC complex and altered 
NF-κβ-signalling appear to drive inflammation in the cpdm skin, the increased 
integrin activity contributes to hyperproliferation and epidermal thickening. Taken 
together, our findings suggest that both aberrant integrin- and LUBAC-mediated 
signalling contribute to the cpdm phenotype. This introduces an intriguing possibility 
that induction of integrin-mediated adhesion and -signalling pathways may 
contribute to or even account for some of the cpdm phenotype features that have so 
far been linked solely to TNF- and NF-κβ-signalling. Furthermore, there may also 
be crosstalk between increased TNF- and integrin-mediated signalling that 
contributes to the cpdm phenotype, but this remains to be investigated. Taken 
together, this study expands our current knowledge of molecular mechanisms 
underlying the SHARPIN cpdm skin phenotype and the systemic inflammation. 
Importantly, investigation of how the distinct binding partners of SHARPIN function 
at tissue level may improve the current understanding of how integrin activity and 
the LUBAC complex regulate inflammation and contribute to psoriasis-like 
conditions. 
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